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Abstract  
One of the major disadvantages of batch fermentation is the difficulty in achieving high cell 
densities; in E.coli K12, much of this is attributed to the production of acetate via a 
phenomenon known as overflow metabolism. Although a fed-batch configuration is the 
standard method for reducing such issues, traditional fed-batch mechanisms require 
components which become problematic when applying them to smaller scale systems such 
as shake flasks. As a result, a number of slow release carbon techniques have been 
developed; one of which uses the enzymatic degradation of starch to slowly release 
glucose into the culture medium following the addition of an amylolytic enzyme. This 
reduces acetate production due to the low initial glucose concentration, leading to an 
increased cell density, and an increased product yield. To date, these amylolytic enzymes 
have been added to the culture exogenously, whereas this project aims to employ a cell 
engineering approach to design and build a self-secreting amylolytic chassis capable of 
enzyme-based fed-batch fermentation. The study explores the use of starch as an 
alternative carbon source, and describes the ability of a highly active amylolytic E. coli 
strain secreting S. thermoviolaceus α-amylase to degrade and utilise starch as a sole carbon 
source. Bacterial exo-acting amylolytic enzymes have been identified and cloned into E. coli 
for characterisation studies, with enhanced secretion of the novel C. violaceum 
glucoamylase using the DsbA signal peptide resulting in direct conversion of starch to 
glucose within the media. Further investigations reveal expression can be negatively 
regulated using a glucose sensitive promoter, providing a basis for self-regulation. Lastly, 
vectors have been constructed to simultaneously express the C. violaceum glucoamylase 
and a target recombinant protein (eGFP), resulting in higher biomass and increased 
recombinant protein expression when grown on starch compared to an equivalent amount 
of glucose, the first demonstration of a cell engineered approach to enzyme-based fed-
batch fermentation.  
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Impact Statement 
 
This thesis describes a novel solution to one of the most fundamental problems associated 
with microbial fermentation, achieving high cell densities and increased recombinant 
protein yields in batch culture. By combing the principles of enzyme-based fed-batch 
fermentation with engineered amylolytic E. coli strains, a proof of concept has been 
demonstrated which has the potential to provide an alternative to current traditional fed-
batch methods. The technology is particularly applicable to lab-scale batch culture, giving 
scientists an ability to increase recombinant protein yield without requiring them to invest 
in small scale fed-batch control systems. This opens up possible commercial opportunities, 
not only competing with currently available enzyme-based fed-batch media products, but 
offering a significant advantage over them whereby the exogenous addition of amylolytic 
enzymes is not required. More broadly, this work highlights the capability of cell 
engineering to enhance bioprocessing, and provides a platform for further projects looking 
to combine this with other innovative cell engineering approaches to improve overall 
bioprocessing efficiencies.  
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1 Introduction  
1.1 Chassis engineering to enhance bioprocessing  
Cell or chassis engineering has been applied widely across the biotechnology industry, 
using a broad range of different host organisms, in an attempt to enhance the efficiency of 
bioprocessing [1]. Much of this has been associated with improving upstream processes, 
encompassing any modifications capable of increasing product yield or reducing cost during 
fermentation [2], although considerable effort has also been directed towards downstream 
capture and purification steps [3], with the general aim of increasing bioprocess 
productivity as a whole.   
One particularly recent example, which has actually proved beneficial to both upstream 
and downstream processes, has been the  development of a triosephoshate isomerase 
knockout E. coli strain, in which auxotrophic complementation provides a mechanism for 
antibiotic-free selection of recombinant plasmids [4]. Plasmid segregational stability is an 
important issue during fermentation, with poor stability leading to a reduced recombinant 
protein yield. Although many research settings use antibiotics as a selective marker, this is 
not the preferable option in industry as scale up not only leads to issues associated with 
the widespread use of antibiotics, but also an increase in both the cost and complexity of 
downstream processing. Chassis engineering has, in this case, provided an alternative to 
antibiotic selection which can address these problems and reduce both overall cost and any 
additional downstream complications. 
Another example, this time where chassis engineering has been applied directly to 
downstream processing, has been the creation of an E. coli strain capable of expressing a 
staphylococcal nuclease which is targeted to the periplasm [5]. Upon homogenisation this 
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nuclease is able to hydrolyse the host cells nucleic acid, significantly reducing the viscosity 
of the homogenate and the subsequent supernatant, tackling a major hindrance to 
downstream processing and purification. With nuclease co-expression compromising 
neither growth nor yield of the production strain, this cell engineering method appears to 
be a very viable option in reducing downstream costs and maximising product 
manufacturability [6].  
To that end, this thesis identifies a particular aspect of bioprocessing which has the 
potential to be enhanced or improved by the application of host cell engineering. More 
specifically it focusses on the difficulty in achieving high cell densities in batch 
fermentations, and describes a cell engineering approach to resolve these challenges.   
1.2 Escherichia coli as a host organism 
Escherichia coli are Gram-negative bacteria used extensively in both research and industrial 
settings. Owing to a rapid growth rate and relative ease to culture, E. coli has been the 
organism of choice for a huge quantity of molecular and cellular research to date. The 
wealth of knowledge gained has helped E. coli become one of the predominant organisms 
in the bioprocess industry, and as such a key target for host cell engineering. A major 
drawback in using this particular organism however, is the difficulty in secreting 
recombinant proteins into the extracellular media; a particularly advantageous feature 
from the perspective of downstream processing and purification. Instead, proteins of 
interest are often constructed to include a targeting sequence which directs them to the 
periplasmic space between the outer membrane and the cytoplasmic membrane. The 
periplasm offers certain advantages over the cytoplasm such as containing fewer proteases 
and providing an oxidative environment conducive to disulphide bond formation [7]. 
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Furthermore, regarding downstream processing, the periplasm contains a much smaller 
number of native cell proteins compared to the cytoplasm, aiding the purification process.  
Although thousands of E. coli strains have been found and developed, there are only four 
(K12, B, C and W) which have been characterised as safe, and which are used widely across 
laboratories and industry [8]. There is a fifth strain (Crooks) which is also commonly used, 
and although it has not yet been designated laboratory safe, it is not known to be 
pathogenic. In addition to this, E. coli Nissle, which was originally isolated in 1917 by Alfred 
Nissle, can actually provide certain health benefits, and as such has been used as a 
probiotic in the treatment of numerous gastrointestinal disorders [9]. For the purposes of 
the current study, work has been carried out in both K12 and B strains, predominantly 
because these strains are some of the most extensively used for recombinant protein 
production in both academia and industry.   
1.2.1 Carbohydrate metabolism within E. coli  
Early experiments by Monod investigating the phenomenon of diauxic growth [10], showed 
E. coli preferentially use glucose over lactose and other sugars, when present in a mixture. 
This has led to a vast amount of work into carbon catabolite repression and carbon 
metabolism pathways predominantly using E. coli as a model. It is now known that glucose 
is transported into E. coli via five different permeases [11]; three of which are of the 
phosphotransferase system (PTS) type, including the regular glucose-PTS, the mannose-PTS 
and the N-acetyl-glucosamine-PTS, and the final two are galactose induced uptake systems, 
the galactose permease and the methyl-galactoside permease [12]. Glucose entering via 
the PTS system is directly converted to glucose-6-phoshate, whereas glucose entering via 
the latter two permeases requires phosphorylation by glucokinase. In either case glucose-
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6-phosphate is the starting molecule for the three major carbon metabolism pathways, 
glycolysis, the tricarboxylic acid cycle, and the pentose phosphate pathway.  
E. coli are also capable of catabolising polymers of glucose. Growth is possible on 
oligosaccharides up to 7 or 8 glucose units in length, any larger and there is an increasingly 
reduced growth rate correlated with the size of the oligosaccharide [13]. Short chained 
glucose polymers, or maltodextrins, are transported via facilitated diffusion into the 
periplasm through the outer membrane transporter protein, maltoporin (LamB) [14]. 
Maltose binding protein (MBP), the malE gene product residing in the periplasm, is 
responsible for recognising maltodextrins and sequestering them to the MalF, MalG, and 
MalK membrane bound complex for transport into the cytoplasm [15]. MBP is capable of 
binding molecules as large as amylose and starch [16], with some evidence suggesting a 
proportional relationship between binding affinity and maltosaccharide chain length [17]. 
Only maltodextrins with a chain length of 6 glucose units or fewer are transported into the 
cytoplasm [18], explaining the difficulty E. coli have in catabolising larger maltodextrins. 
The combined action of three cytoplasmic enzymes, amylomaltase, maltodextrin 
phosphorylase, and maltodextrin glucosidase, degrade these maltodextrins to form glucose 
and α-glucose-1-phosphate. These two molecules require the presence of glucokinase and 
phosphoglucomutase for their respective conversions to glucose-6-phosphate and 
subsequent entry into central carbon metabolism pathways [19].      
In the context of fermentation, the carbon source on which E. coli can achieve their highest 
growth rate is in most conditions glucose [20], however the provision of glucose at high 
concentrations, when E. coli are cultured aerobically, can lead to a phenomenon known as 
overflow metabolism, ultimately reducing growth rate and product yield [21, 22]. 
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1.2.2 Acetate production and overflow metabolism  
During rapid glucose uptake in aerobic conditions, the flux of acetyl-coA is directed away 
from the tricarboxylic acid (TCA) cycle and towards the production of acetate in a process 
known as overflow metabolism [23]. This phenomenon leads to a diversion of carbon away 
from potential biomass and recombinant protein product, as well as resulting in acetate 
accumulation in the media lowering pH, leading to both a reduction in growth [22] and 
recombinant protein yield [21]. Overflow metabolism occurs when cells grow above a 
threshold specific growth rate, with the threshold being strain dependant and linked to the 
cells maximum oxygen uptake rate. Under glucose limited growth, the growth rate can be 
controlled by reducing the availability of glucose, which provides the basis of fed-batch 
fermentation (see section 1.3.1). The molecular mechanisms behind overflow metabolism 
are yet to be fully resolved, particularly regarding its regulation, however, there is evidence 
to suggest it arises due to a limitation in the respiratory system whereby NADH is unable to 
be re-oxidised at a sufficient rate [24]. Given that the flux from acetyl-CoA through the TCA 
cycle produces NADH, whereas the flux from acetyl-CoA to acetate does not, this could be a 
mechanism to prevent further accumulation of reduced co-factors within the cell.  
Acetate production itself is fairly well understood, with the predominant pathway involving 
the phosphate acetyl-transferase (Pta) and acetate kinase (AckA) enzymes, which convert 
acetyl-coA to acetyl-phosphate, and acetyl-phosphate to acetate respectively [25], and a 
secondary pathway involving the oxidative decarboxylation of pyruvate by pyruvate 
oxidase (PoxB) (Fig 1.1) [26, 27].  
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Figure 1.1 Schematic diagram of acetate production in E. coli central metabolism  
Acetate production in E. coli central carbon metabolism via the Pta/AckA or the PoxB 
pathways.  
 
1.3 Methods to alleviate the effects of acetate production  
Numerous methods have been developed in an effort to overcome the detrimental effects 
of acetate on E. coli recombinant protein fermentations [28]. This section outlines these 
attempts with the aim of providing a context to the current project. 
1.3.1 Fed-batch fermentation  
As discussed, the development of traditional glucose-limited fed-batch fermentation has 
gone some way to alleviate acetate accumulation, and is the method most commonly used 
in industry for achieving high cell densities and increased recombinant protein yield. These 
traditional systems vary extensively in the manner of substrate delivery; some are 
programmed with pre-determined feed rates e.g. constant or exponential, while others rely 
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on automatic feedback control [29]. Regardless of the mechanism, traditional fed-batch 
fermentation is often an impractical solution for smaller scale fermentations owing to the 
sophistication of the control systems required, as well as other technical difficulties 
including unsatisfactory flow and mixing of small, concentrated feed volumes. Many of 
these issues are being challenged through the development and increased availability of 
miniature bioreactors, for example the ambr® 250 from Sartorious or the DASbox® from 
Eppendorf, however shake flasks still provide an inexpensive and effective way of 
reproducibly performing many types of industrially-relevant cell cultivations for process 
development, and are therefore still widely used across industry and academia [30]. 
An alternative approach to the traditional fed-batch fermentation concept, which is 
relevant to shake flasks, has been the development of substrate delivery via an internal 
supply mechanism [31, 32]. An example specific to glucose supply uses silicone elastomer 
discs containing glucose crystals which, when immersed in media, release glucose by 
diffusion [33]. This has had the result of significantly increasing biomass yield, as well as 
potential recombinant protein expression. Another, more recent slow-release innovation, 
has been the idea of releasing glucose from its polymeric form via enzymatic degradation 
[34]. This system provides a basis for the current project and is discussed in more detail 
below (section 1.4).        
1.3.2 Cell and Metabolic engineering 
Other attempts at limiting acetate accumulation have been focussed on cell and metabolic 
engineering strategies. Broadly these have aimed at either reducing glucose consumption 
or reducing acetate production. As already discussed, glucose uptake is controlled 
predominantly by the PTS system; when knocked out and replaced with galactose 
permease the effect on glucose metabolism is a reduction in acetate accumulation and a 
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subsequent improvement of fermentation product yield [35, 36]. Another successful 
method of limiting glucose uptake has been to overexpress the PTS repressor protein Mlc, 
through modification of the mlc promoter, resulting in a 50% reduction in acetate and an 
associated increase in protein yield [37]. A number of methods have also been used to 
reduce acetate production directly, by diverting the flux of carbon away from acetate 
formation, either by targeting the enzymes responsible for its formation or by diverting the 
carbon to other compounds which are not as detrimental to growth and protein 
expression. An example of the former is seen following the mutation of the Pta gene, 
eliminating phosphotransacetylase [21], an enzyme involved in the primary pathway for 
acetate formation. A downside to this particular target is a subsequent increase in either 
lactate or pyruvate. The latter approach includes the introduction of enzymes which 
convert molecules residing at the end of glycolysis into compounds other than acetate. An 
example being the introduction of acetolactate synthase from Bacillus subtilis which 
converts pyruvate to acetoin, the effect of which doubled recombinant protein yield [38]. 
The major problem with some of these methods is that they do not necessarily prevent the 
diversion of carbon away from more useful forms such as biomass or product yield. An 
alternative genetic approach has been to divert acetate precursors towards the carboxylic 
acid cycle whereby the carbon can remain available to the cell. Overexpression of 
phosphoenolpyruvate (PEP) carboxylase, which converts PEP (an acetate precursor) to 
oxaloacetate, is able to significantly reduce acetate formation [39], however this in turn 
lowers the amount of PEP available for PTS-mediated glucose uptake which decreases 
overall growth rate [40]. Attempts have also been focussed on the potential molecular 
causes of overflow metabolism, as seen when excess NADH is removed by the recombinant 
expression of a Streptococcus pneumoniae NADH oxidase, allowing for a 10% increase in 
model protein expression [41].                
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1.3.3 Media composition strategies 
Given that glucose in particular leads to acetate accumulation, previous studies have 
shown that replacing glucose with other utilisable carbon sources such as mannose [42] or 
fructose [43] can reduce acetate and subsequently increase biomass and recombinant 
protein expression. Despite the reduced maximum growth rate, there is evidence to 
suggest glycerol, when used as a carbon source post induction, is superior to glucose in 
terms of reducing acetate accumulation [44]. It has also been demonstrated that 
supplementing defined media with certain amino acids such as glycine and methionine can 
alleviate the inhibition of the specific growth rate caused by acetate [45]. Carbon sources 
are not the only area of interest, a recent study has presented the idea of implementing an 
alkaline shift, where by E. coli are cultured at pH8 in order to minimise the effects of 
acetate stress, improving both cell growth and recombinant protein expression [46].   
1.3.4 Strain selection 
It is known that central carbon metabolism varies between differing E. coli strains. B strains 
such as BL21(DE3) are able to employ a glyoxylate shunt resulting in reduced acetate levels, 
a mechanism beyond the capability of K12 strains [47-51]. As such K12 strains are more 
susceptible to the detrimental effects of overflow metabolism, an aspect explored further 
in this study with respect to selecting a suitable host to apply a cell engineering approach 
to control carbon utilisation.  
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1.4 Enzyme-based fed-batch fermentation  
An alternative approach to traditional fed-batch fermentation is to provide the culture with 
necessary glucose in batch, but in a form which is not metabolically active i.e. using a 
polymerised version of glucose such as starch, and accessing the glucose via the use of 
amylolytic enzymes.  
1.4.1 Current strategies 
A current strategy developed by BioSilta, which has already been commercialised, uses the 
concept of glucose limited fed-batch fermentation, but rather than from an external feed, 
glucose is instead provided to the cells via the enzymatic degradation of starch [34] i.e. 
metabolically inactive polysaccharide is converted into metabolically active 
monosaccharide  following the addition of an amylolytic enzyme (in this case an 
amyloglucosidase or glucoamylase isolated from A. niger (E.C.3.2.1.3.; Amylase AG 300L, 
Novozymes, Bagsvaed, Denmark)). Initially, starch is added to the culture flask in the form 
of a storage gel from which it continuously dissolves into the medium. The rationale for 
using a storage gel was based on the assumption that one gram of glucose yields 
approximately 0.5 g (dry weight) of cells and as such the developers needed to design a 
system which could supply enough glucose to reach desired cell densities. The developers 
embedded the gels with 10 % (100 g/L) starch, which they calculated would be enough to 
give a theoretical cell density of 30 g/L dry cell weight. This is equivalent to an OD600 of 
approximately 100. Their experimental work to determine the most appropriate 
concentration of glucoamylase found that glucose limited growth controlled by enzymatic 
degradation could reach an optimum cell density with an OD600 of 20 to 30, or 
approximately 6 to 9 g/L dry cell weight. Importantly, during experiments in which cell 
density achieved these high levels, acetate accumulation remained low, and pH and pO2 
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remained stable. In contrast, when higher concentrations of the enzyme were tested, cell 
density fell away to an OD600 of 10, highlighting the importance of glucose concentration in 
the media and its correlation with cell density.  
Later modifications and subsequent commercialisation led to the development of Biosilta’s 
EnPresso® growth system which incorporates the necessary nutrients and supply of starch 
within two tablets. These are added to sterile water at both the beginning and again part 
way through the culture period (see section 2.4.4 for protocol details). The EnPresso® 
growth system was used during this study as a proof of concept for a cell engineering 
approach to enzyme-based fed-batch fermentation.    
1.4.2 Cell engineering approach to enzyme-based fed-batch fermentation 
An important aspect of the EnPresso® growth system described above is the required 
addition of glucoamylase throughout the culture. Although undeniably easier than 
providing a constant feed of glucose, it still to some extent defeats the original objective. A 
cell engineering approach, however, in which a cell expresses and secretes its own 
amylolytic enzyme, would provide a number of advantages. Firstly it would alleviate the 
need for an experimenter to intervene at multiple points during the culture, and secondly 
the expression of the amylolytic enzyme could be regulated in such a way to provide 
glucose at a rate correlated to cell density, or indeed controlled via a feedback mechanism 
linked to culture conditions i.e. glucose concentration. This study is concerned with 
applying an innovative solution to overflow metabolism by designing and constructing an E. 
coli chassis which is capable of self-secreted enzyme-based fed-batch fermentation.     
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1.5 Amylolytic enzymes and their substrates 
Amylolytic enzymes or amylases constitute one of the most significant classes of enzymes 
within biotechnology, and are applied across industries as diverse as food, textile, paper 
and detergent manufacturing [52]. Given the abundance of their substrate, starch, and the 
importance of starch as a biological energy store, a wealth of different amylases are 
produced by organisms across every domain of life. Recent attempts to classify amylolytic 
enzymes have been based on their structure and primary sequence [53], and have been 
compiled in the Carbohydrate Active Enzyme (cAZY) database [54], a resource used in this 
study to identify putative enzymes for characterisation. One aspect of considerable 
importance is the product profile following starch hydrolysis, which varies greatly 
depending on class of amylolytic enzyme used. The two classes used extensively 
throughout this project are the endo-acting α-amylase (EC 3.2.1.1) (primarily Glycoside 
hydrolase family 13) (section 1.5.2) and the exo-acting glucoamylase (EC 3.2.1.3) (Glycoside 
hydrolase family 15) (section 1.5.3).  
1.5.1 Starch 
Starch, an amylolytic enzyme substrate, is a heterogeneous polysaccharide consisting of 
amylose, a water insoluble linear polymer of glucose linked by α-1,4 glycosidic bonds, and 
amylopectin, a water soluble branched polymer of glucose containing both α-1,4 and α-1,6 
glycosidic bonds [55]. Traditionally the relationship between biotechnology and amylolytic 
enzymes has been one of microbial production for use in the starch industry. However, it is 
also possible to utilise starch directly for conversion into useful and/or valuable products. 
As mentioned previously, starch is a ubiquitous source of biomass and as such has the 
potential to provide an excellent source of carbon for fermentative processes. Given that 
starch is a natural precursor to glucose, and often forms part of agricultural waste streams, 
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its production has the potential to be more economically viable than that of glucose. 
Currently however, compared to soluble potato starch, the type of starch used throughout 
this study, glucose remains the least expensive option, presumably due to the disparity in 
manufacturing scales.  
Until recently there have been very few attempts at engineering E. coli to utilise starch 
directly [56]. This study explores the use of soluble potato starch as an alternative carbon 
source in E. coli fermentation, and investigates a potential increase in achievable biomass 
through a controlled release of glucose via its direct enzymatic degradation.  
1.5.2 α-amylases 
The most common and well characterised class of amylolytic enzymes are α-amylases (EC 
3.2.1.1), which hydrolyse the α-1,4 glycosidic links within the constituent polysaccharides 
of starch (amylose and amylopectin), to form shorter chain maltodextrins. Both activity and 
substrate specificity of α-amylases vary, but a common feature is endo-activity, meaning 
they predominantly generate oligosaccharides rather than glucose.   
1.5.2.1 S. thermoviolaceus α-amylase  
The α-amylase used in this study was originally cloned from Streptomyces thermoviolaceus 
(CUB74 strain) [57], and has since been sequenced [58]. The gene encodes a 460 amino 
acid protein which, following cleavage of a 28 amino acid signal peptide, has a molecular 
weight of 47 kDa [58]. Paper chromatographic analysis has indicated that the major 
hydrolysis products of S. thermoviolaceus α-amylase are maltotetraose, maltotriose and 
maltose [57]. Although the initial rationale for cloning the S. thermoviolaceus α-amylase 
was to express a recombinant thermophilic α-amylase in E. coli, for potential use in the 
starch industry, the enzyme became a useful tool for investigating the properties of protein 
retention within the periplasm. The native signal sequence targets S. thermoviolaceus α-
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amylase to the periplasm where a certain proportion of the enzyme is able to leak out into 
the extracellular media. The ease with which the activity of amylase can be determined by 
measuring the degradation of starch using potassium iodide/iodine solution, along with the 
thermophilic nature of this particular amylase (providing an opportunity to reduce the 
possibility of any activity from endogenous amylases by using an increased temperature) 
allowed for the development of an assay to determine activity within extracellular, 
periplasmic, or cytoplasmic fractions (see section 2.5.5). As a result the method was used 
to investigate the variation in outer membrane permeability across multiple E. coli strains 
(C. French and J. Ward, unpublished).  
1.5.2.2 The derivation of pQR187 
In this study S. thermoviolaceus α-amylase has been expressed using the vector pQR187. 
pQR187 was constructed and supplied by J. Ward (unpublished). The original cloning of the 
S. thermoviolaceus α-amylase gene [57] was carried out using E. coli JM107 transformed 
with pUC8 containing the BamHI genomic library of S. thermoviolaceus. The one colony 
displaying extensive amylase activity, detected via starch hydrolysis, contained a 
recombinant plasmid, designated pQR300, (pUC8 containing a 5.7 kb insert). Cloning the 
5.7 kb BamHI fragment in the opposite orientation to the lacZ promoter (pQR303) resulted 
in amylase negative E. coli colonies, meaning expression of the α-amylase gene was 
regulated by the lacZ promoter rather than a native promoter. From mapping and sub-
cloning experiments it was found that the coding sequence of the gene was localised to a 
1.7 kb BamHI-SphI DNA fragment (pUC18 containing the 1.7 kb BamH1-Sph1 insert was 
designated pQR307) [57]. A 3.4 kbp Hindlll/Pstl fragment containing the S. thermoviolaceus 
α-amylase gene was excised from pQR300 and cloned into pBGS19 to form pQR126. This 
particular sub-cloning step removed a 150 bp region of upstream DNA which contained the 
endogenous promoter. The reduced distance between the translational start site and the 
lacZ promoter allowed for a fivefold increase in production of α-amylase [59]. pBGS19 itself 
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is a 4.4 kbp kanamycin resistant pUC analogue which contains the multiple cloning region 
from pUC19 (multiple cloning site originally derived from M13mp19) [60]. pQR126 was 
later modified to contain a Pstl/EcoRl 200 bp cer fragment from pKS450 (a pUC-based 
vector containing the cer region from ColE1 [61]), to increase the segregational stability of 
the plasmid [62], forming pQR187.      
1.5.3 Glucoamylases 
Glucoamylases, or amyloglucosidases (EC 3.2.1.3), hydrolyse terminal α-1,4 glycosidic links 
successively from the non-reducing ends of polysaccharides. This exo-acting ability 
predominantly generates glucose as opposed to other maltodextrins. The majority of 
previously characterised glucoamylases are of fungal origin, primarily from Aspergillus 
niger and Rhizopus oryzae [63], and are the leading type used in industry. For the most 
part, fungal glucoamylases are highly glycosylated, which is thought to be important for 
their stability [64], meaning they are often difficult to successfully express in E. coli. 
However, a notable exception includes the heavily glycosylated glucoamylase STA1 from 
Saccharomyces cerevisiae (var. diastaticus), which has been successfully expressed in E. coli 
previously [65]. Owing to the lack of examples in the literature, an aspect of this project 
involves the identification and characterisation of putative bacterial glucoamylases, to 
facilitate expression and secretion within a starch utilising E. coli chassis. One of the few 
examples of a bacterially derived glucoamylase which has been heterologously expressed 
in E. coli is the thermostable glucoamylase (TtcGA) from Thermoanaerobacter 
tengcongensis MB4 [66]. This was initially carried out to investigate an alternative and a 
possible improvement to traditional thermostable enzymes of fungal origin for industrial 
applications. Despite not necessarily requiring thermostability in this particular application, 
TtcGA has provided a basis for the identification and characterisation of other novel 
putative bacterial glucoamylases. 
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1.6 Secretion of amylolytic enzymes within E. coli 
As previously stated, one of the draw backs of using E. coli as an expression system is the 
difficultly associated with recombinant protein secretion. Much of the rationale behind this 
particular project is based on previous work by C. French and J. Ward (unpublished) 
investigating periplasmic release as a method of protein extraction for downstream 
processing. The work compared periplasmic retention in a number of different K12 strains 
including W3110, and highlighted the ability of E. coli to secrete a periplasmically targeted 
amylolytic enzyme into the surrounding culture medium. This idea has been extended in 
this study to further characterise secretion via periplasmic leakage, and investigate 
whether this is a viable method to engineer E. coli to utilise starch as a carbon source and 
ultimately provide a basis for a self-secreting enzyme-based fed-batch fermentation 
system. The initial work carried out by C. French and J. Ward indicated potential differences 
between different E. coli strains in the periplasmic retention of protein (unpublished), a 
factor which could influence strain selection when designing a system based on periplasmic 
leakage. There is also the possibility that different proteins may have differing levels of 
retention within the periplasm, another factor which has the potential to influence the type 
of amylolytic enzyme used, and the subsequent ability to degrade starch extracellularly. 
Regarding the targeting of amylolytic enzymes to the periplasm in the first place, S. 
thermoviolaceus α-amylase contains a native signal sequence, but exogenous sequences 
have also been explored following fusion to novel bacterial glucoamylases in an attempt to 
improve secretion. The translocation of polypeptides across the cytoplasmic membrane 
into the periplasm of Gram-negative bacteria can occur by three main pathways; the sec 
pathway [67], the signal recognition particle (SRP) pathway [68] and the Tat pathway [69]. 
Both the Sec and SRP pathways use the SecYEG channel protein for translocation; however 
the signal peptide directing the former is recognised by the SecB protein whilst signal 
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peptides directing the latter are recognised by the SRP protein. The two binding proteins 
recruit different translocation machinery leading to unfolded post-translational 
translocation and co-translational translocation respectively. In contrast, the third pathway, 
the Tat pathway, primarily translocates fully folded proteins and uses its own distinct 
channel protein, TatA [70]. Two previously characterised and widely used signal peptides 
are investigated in this study, the DsbA signal sequence (originally derived from thiol 
disulfide oxidoreductase found in many bacterial species including E. coli) [71] [72] (SRP 
pathway) and the PelB signal sequence (originally derived from the pectate lyase B from 
Pectobacterium carotovorum) [73] (Sec pathway), as well as native signal peptides if 
present.  
As a clarification, this study will refer to secretion as the targeting of amylolytic enzymes to 
the periplasm and their subsequent release into the extracellular media via the leakage of 
periplasmic contents.  
1.7 Regulatory strategies for enzyme expression  
The expression of an amylolytic enzyme within a self-secreting fed-batch system can be 
regulated in a number of different ways depending on the desired outcome. Much of the 
initial work carried out in this study uses the S. thermoviolaceus α-amylase regulated by the 
lac promoter, using Isopropyl β-D-1-thiogalactopyranoside (IPTG) as the inducer. However, 
within a fed-batch system it would be preferable to avoid the necessity of induction, as this 
requires external input and to some extent defeats the original purpose. If a constitutive 
promoter is used, a great deal of fine tuning would be required to determine the 
appropriate level of expression, and even then expression levels may not be optimal 
throughout the whole culture. Alternatively, if the amylolytic enzyme is negatively 
regulated by its own hydrolysis product, theoretically a constant concentration of glucose 
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within the media could be maintained throughout the culture. In this study a novel 
glucoamylase from Chromobacterium. violaceum has been cloned and expressed in E. coli 
under a Cyclic Adenosine Monophosphate (cAMP) sensitive promoter. This glucose 
repressible promoter (PcstA) was derived from E. coli JM109 and is ordinarily involved in 
the regulation of carbon starvation response genes (cstA) which are up regulated during 
glucose starvation [74]. The mechanism behind this is based on the ability of cAMP to 
induce conformational change in the catabolite gene activator protein (CAP), enhancing its 
binding to CAP-dependent promoters [75], and promoting expression. In the absence of 
glucose, levels of intracellular cAMP are increased [76], leading to the binding of CAP to the 
promotor and subsequent transcription of target genes. In high glucose concentrations, 
intracellular cAMP is reduced, leading to a reduction in bound CAP, and a subsequent 
reduction in gene transcription. Based on previous work by the 2008 Edinburgh iGEM team, 
PcstA has been shown to be sensitive to glucose within the range of 0-10 mM, 
corresponding to 0-2 mg/mL, well within the range typically used in traditional fed-batch 
fermentation [77].  
1.8 Overview of project 
In summary, this project aims to investigate the potential use of starch as an alternative 
carbon source in E. coli fermentation, and in doing so applies a cell engineering approach to 
enzyme-based fed-batch fermentation. Chapter 3 highlights the ability of E. coli to 
heterologously express and secrete S. thermoviolaceus α-amylase, to not only degrade 
starch at rates not previously reported, but also to utilise as a sole carbon source. Chapter 4 
includes the identification and characterisation of novel bacterial glucoamylases, the 
optimisation of their secretion, and the subsequent creation of an E. coli strain which can 
convert starch directly to glucose. The final Chapter focusses on developing these 
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amylolytic strains and applying them in a self-secreting enzyme-based fed-batch 
fermentation system, to enhance both biomass and recombinant protein yield in shake 
flasks.   
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2 Materials and Methods 
2.1 Cell culture 
2.1.1 E. coli strains  
The E. coli strains used for growth and expression experiments within this study were the 
K12 strain W3110 (F- λ- rph-1 Inv(rrnD-rrnE)) [78], and the B strain BL21(DE3) [79] (F– ompT 
gal dcm lon hsdSB(rB–mB–) gal dcm (DE3) (Novagen). HST08 (StellarTM chemically 
competent, Clonetech) and TOP10 (chemically competent, Thermo Fisher Scientific) were 
used for sub-cloning experiments.   
2.1.2 Constructs 
Plasmid constructs used in this study, and their descriptions are shown in table 1. 
 
Table 1 Constructs used within current study 
 
Plasmid Description Reference 
pQR187 pBGS19 derivative, lac promoter, Kanr J. Ward (unpublished) 
pQR1700 Modified pQR187, lac promoter, Kanr This study 
pEX-K4-niger_Gluc Sub-cloning vector containing A. niger 
glucoamylase, Kanr 
Eurofins Genomics 
pET29a(+) T7 promoter, Kanr Novagen 
pQR1701 pET29a containing A. niger 
glucoamylase, T7 promoter, Kanr 
This study 
pQR1702 pET29a containing S. diastaticus 
glucoamylase, T7 promoter, Kanr 
This study 
pQR1703 pET29a containing D. geothermalis 
glucoamylase, T7 promoter, Kanr 
This study 
pQR1704 pET29a containing T. tengcongensis 
glucoamylase, T7 promoter, Kanr 
This study 
pQR1705 pET29a containing C. violaceum 
glucoamylase, T7 promoter, Kanr 
This study 
pET28a(+) T7 promoter, Kanr Novagen 
38 
 
Plasmid Description Reference 
pQR1706 pET28a containing D. geothermalis 
glucoamylase, T7 promoter, Kanr 
This study 
pQR1707 pET28a containing T. tengcongensis 
glucoamylase, T7 promoter, Kanr 
This study 
pQR1708 pET28a containing C. violaceum 
glucoamylase, T7 promoter, Kanr 
This study 
pQR1709 pQR1703 with DsbA signal sequence, 
T7 promoter, Kanr 
This study 
pQR1710 pQR1703 with PelB signal sequence, T7 
promoter, Kanr 
This study 
pQR1711 pQR1705 lacking native signal 
sequence, T7 promoter, Kanr 
This study 
pQR1712 pQR1711 with DsbA signal sequence, 
T7 promoter, Kanr 
This study 
BBa_K118011 pSB1C3 containing PcstA, Camr iGEM 2016 Distribution Kit  
pQR1344 pET29a containing eGFP, T7 promoter, 
Kanr 
D. Dobrijevic (unpublished) 
pQR1714 BBa_K118011 containing eGFP, PcstA, 
Camr 
This study 
pQR1715 BBa_K118011 containing C. violaceum 
glucoamylase with attached DsbA 
signal sequence, PcstA, Camr 
This study 
pQR411 pMMB67HE containing E. coli TK, native 
TK constitutive promoter, Ampr 
Ingram et al 2007 [80] 
pUC19 lac promoter, Ampr Yanisch-Perron et al 1985 
[81] 
pQR1716 pUC19 containing S. thermoviolaceus α-
amylase, lac promoter, Ampr 
This study 
pQR1717 pUC19 containing eGFP, lac promoter, 
Ampr 
This study 
pQR1718 pUC19 containing S. thermoviolaceus α-
amylase followed by eGFP, lac 
promoter, Ampr 
This study 
pQR1719 pUC19 containing eGFP followed by S. 
thermoviolaceus α-amylase, lac 
promoter, Ampr 
This study 
pQR1720 pUC19 containing eGFP followed by C. 
violaceum glucoamylase with DsbA 
signal sequence, lac promoter, Ampr 
This study 
Kanr – Kanamycin resistance, Ampr – Ampicillin resistance, Camr – Chloramphenicol 
resistance  
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2.1.3 Strain maintenance 
E. coli strains and constructs were maintained and propagated using selective LB agar 
plates. Glycerol stocks were prepared by re-suspending a colony off a selective plate in 5 
mL LB (with appropriate antibiotic) and incubating overnight at 37°C. 500 µL of culture was 
then added to a cryovial containing 500 µL of 50% (w/v) glycerol and stored at -80°C. 
Antibiotics and other supplements were used where necessary at the following 
concentrations: kanamycin (20 µg/mL); ampicillin (50 µg/mL); chloramphenicol (30 µg/mL); 
IPTG (0.4 mM); and starch (soluble potato starch, Sigma) at 7.5 mg/mL for LB agar plates.   
2.1.4 Competent cell preparation 
To prepare chemically competent cells, 500 µL of overnight culture of E. coli W3110 or 
BL21(DE3) was used to inoculate 50 mL LB for incubation at 37°C, 250 rpm. When the 
culture reached an OD600 of 0.3-0.4, cells were harvested by centrifugation for 10 minutes 
at 2000 g, at 4°C. The pellet was re-suspended in 10 mL of ice-cold 100 mM MgCl2 and then 
centrifuged again for 10 minutes at 2000 g, at 4°C. The pellet was re-suspended in 1.25 mL 
ice-cold 100 mM CaCl2 and incubated on ice for 90 minutes. Following the 90 minute 
incubation, 200 µL of 50% glycerol was added to the cell suspension, which was 
subsequently aliquoted into vials for storage at -80°C. For transformation of newly 
constructed vectors high efficiency competent cells were used (StellarTM Competent Cells, 
Clontech, or TOP10 Competent cells, Thermo Fisher Scientific).  
2.1.5 Transformation 
For pre-prepared chemically competent cells, aliquots were removed from -80°C storage 
and thawed on ice. Once equilibrated on ice either 4 µL of ligation or 1 µL (of 20 ng/µL) 
plasmid DNA was added to 50 µL of thawed cells, mixed and incubated on ice for a further 
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45 minutes. Cells were heat shocked at 42°C for 90 seconds, left on ice for a further two 
minutes, and then added to 1 mL of LB medium. This was incubated at 37°C for one hour 
before plating (50 – 100 µL of cell suspension evenly spread per agar plate, and incubated 
at 37°C for 18 hours). The transformation protocol for high efficiency competent cells 
varied slightly in that the DNA/thawed cells mixture was incubated on ice for 30 minutes 
and the heat shock was 42°C for 45 seconds, followed by addition of 450 µL of pre warmed 
S.O.C medium (2% tryptone, 0.5% yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 
10 mM MgSO4, and 20 mM glucose) (Thermo Fisher Scientific).     
2.2 Standard molecular biology techniques 
2.2.1 Vector design, construction and confirmation  
All vectors, primers and oligonucleotides were designed using SnapGene (version 1.1.3) 
software. Oligonucleotides were synthesised and supplied by Eurofins Genomics. For use in 
PCR (see section 2.2.3), lyophilised oligonucleotides were re-suspended in miliQ water and 
diluted to a concentration of 10 µM. For use in ligation (see section 2.2.2), equimolar 
concentrations of complementary oligonucleotides were mixed, heated to 98°C and 
allowed to cool to room temperature. Vectors were constructed using traditional 
restriction digestion and ligation (section 2.2.2) or by circular polymerase extension cloning 
(section 2.2.4). Confirmation of correct construction was carried out by restriction analysis 
and sequencing (Source Bioscience or Eurofins Genomics). 
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Table 2 Nucleotide sequences for primers and oligonucleotides used in vector 
construction  
 
Primer/Oligo Nucleotide Sequence  Vector(s) 
constructed  
Forwardamy2.1 ACTGAAGCTTTAATGATAAGGAGGACAGCTATG
GCCAGCAGAACGCTCTCGGGCGCG 
pQR1700 
Reverseamy2 AGCTCTGCAGTCAGCAGCTCGTCCTGCCGTTGTG
CAG 
 
diast_Gluc forward TGGTGCTCGAGTTAGTTCCCCGTCT pQR1702 
diast_Gluc reverse GAAGGAGATATACATATGGTAGGCCTCAAAAAT
CC 
 
ABF45027.fw ATTCGACATATGAGTGACGCTTCCGC pQR1703, 
pQR1706 
ABF45027.rv ATCAAGCTCGAGTCACCCGTTCTGCGCG  
Q8R917_3.Fw ATTCGACATATGTTGAAGAGGATTGGAAT pQR1704, 
pQR1707 
Q8R917_3.Rv ATCAAGCTCGAGTTATCTCTCCCCTAATACATAC  
AAQ61151.fw ATTCGACATATGAAACACCCGTCCCTG pQR1705, 
pQR1708 
AAQ61151.rv ATCAAGCTCGAGTCACCAGTTCACCTGATCAT pQR1705, 
pQR1708 
AAQ61151.rv ATCAAGCTCGAGTCACCAGTTCACCTGATCAT pQR1711 
AAQ61151_2.fw ATTCGACATATGGGGGAGGCATTCGGC  
PcstA_eGFP.Rv TACTAGTAGCGGCCGCTGCAGTTACTTGTACAGC
TCGTC 
pQR1714 
PcstA_rbsGFP.fw GCCGCTTCTAGAAGGAGTAAATAATGGTGAGCA
AGGGC 
 
K118011-CVprimer2-Dsb TTCCCCTCTAGAAGGAGTAAATAA pQR1715 
K118011_CV1.rv ATCAAGGATCCTCACCAGTTCACCTGAT  
K118011Bamh1.fw CATGATGGATCCTCCGGCAAAAAAGGGC  
K118011Bamh1.rv GGCCGCTACTAGTATGTC  
AmyCPEC1.fw GGCCAGTGAATTCTCAGCAGCTCGTCCT pQR1716 
AmyCPEC1.rv CACACAGGAAACAGCTATGGCCAGCAGAACG  
pUC19CPEC1.fw CGTTCTGCTGGCCATAGCTGTTTCCTGTGTG  
pUC19CPEC1.rv AGGACGAGCTGCTGAGAATTCACTGGCC  
CPEC2_GFP.fw ACGGCCAGTGAATTCTTACTTGTACAGCTCG pQR1717 
CPEC2_GFP.rv ACACAGGAAACAGCTATGGTGAGCAAGGG  
CPEC2_pUC19.fw CCCTTGCTCACCATAGCTGTTTCCTGTGT  
CPEC2_pUC19.rv CGAGCTGTACAAGTAAGAATTCACTGGCCGT  
AmyCPEC1.rv CACACAGGAAACAGCTATGGCCAGCAGAACG pQR1718 
CPEC2_GFP.fw ACGGCCAGTGAATTCTTACTTGTACAGCTCG  
CPEC2_pUC19.rv CGAGCTGTACAAGTAAGAATTCACTGGCCGT  
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Primer/Oligo Nucleotide Sequence  Vector(s) 
constructed  
CPEC7_Amy.fw CTTGCTCACCATTATTTACTCCTTCAGCAGCTCG pQR1718 
CPEC7_GFP.rv CGAGCTGCTGAAGGAGTAAATAATGGTGAGCAA
G 
 
pUC19CPEC1.fw CGTTCTGCTGGCCATAGCTGTTTCCTGTGTG  
CPEC8_Amy.fw ACGGCCAGTGAATTCTCAGCAGCTC pQR1719 
CPEC8_Amy.rv GCTGTACAAGTAAAGGAGTAAATAATGGCCAGC
AGA 
 
CPEC8_GFP.fw TCTGCTGGCCATTATTTACTCCTTTACTTGTACAG
C 
 
CPEC8_GFP.rv CACACAGGAAACAGCTATGGTGAGCAAGG  
CPEC8_pUC19.fw CCTTGCTCACCATAGCTGTTTCCTGTGTG  
CPEC8_pUC19.rv GAGCTGCTGAGAATTCACTGGCCGT  
CPEC8_GFP.rv CACACAGGAAACAGCTATGGTGAGCAAGG pQR1720 
CPEC8_pUC19.fw CCTTGCTCACCATAGCTGTTTCCTGTGTG  
CPEC9_CVprimer2Dsb.fw ACGGCCAGTGAATTCTCACCAGTTCAC  
CPEC9_CVprimer2Dsb.rv GCTGTACAAGTAAAGGAGTAAATAATGAAAAAA
ATTTGGCTG 
 
CPEC9_GFP.fw CAGCCAAATTTTTTTCATTATTTACTCCTTTACTTG
TACAGC 
 
CPEC9_pUC19.rv GTGAACTGGTGAGAATTCACTGGCCGT  
DsbAss forward CTAGAAGGAGTAAATAATGAAAAAAATTTGGCT
GGCGCTGGCGGGCCTGGTGCTGGCGTTTAGCGC
GAGCGCGCA 
pQR1709, 
pQR1712 
DsbAss reverse TATGCGCGCTCGCGCTAAACGCCAGCACCAGGC
CCGCCAGCGCCAGCCAAATTTTTTTCATTATTTAC
TCCTT 
 
PelBss forward CTAGAAGGAGTAAATAATGAAATATCTGCTGCC
GACCGCGGCGGCGGGCCTGCTGCTGCTGGCGG
CGCAGCCGGCGATGGCGCA 
pQR1710 
PelBss reverse TATGCGCCATCGCCGGCTGCGCCGCCAGCAGCA
GCAGGCCCGCCGCCGCGGTCGGCAGCAGATATT
TCATTATTTACTCCTT 
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2.2.2 Restriction digestion and ligation  
Restriction enzymes were obtained from New England Biolabs. For a typical digest with a 
total volume of 25 µL, 5 units of restriction enzyme was used to digest up to 0.5 µg of DNA, 
along with 2.5 µL of associated 10X NEBuffer. Reactions were carried out at 37°C for 1-3 
hours. For further use of DNA in ligation reactions restriction enzymes were heat 
inactivated by incubation at 70°C for 10 minutes. Ligation reactions were carried out 
overnight at room temperature using T4 DNA ligase (New England Biolabs). A typical 
ligation reaction with a total volume of 20 µL contained 1 µL T4 DNA ligase, 2 µL 10X T4 
DNA ligase buffer and 50 ng of vector DNA, with insert amount calculated using a 1:3 vector 
to insert molar ratio (NEBiocalculator).   
2.2.3 Polymerase chain reaction (PCR) 
PCR reactions used Phusion® High-Fidelity PCR master mix with HF Buffer (New England 
Biolabs). Typical PCR reactions with a total volume of 20 µL contained 10 µL of 2X Phusion 
Master Mix, 1 µL of each primer (10 µM) and less than 10 ng of template (plasmid) DNA (or 
up to 250 ng of genomic DNA). Thermo-cycling conditions included an initial denaturation 
period of 30 seconds at 98°C, followed by 25 cycles of denaturation (98°C for 15 seconds), 
annealing (45-72°C, or approximately 2°C below the lowest primer Tm, for 30 seconds), and 
extension (72°C for 30 seconds per 1000 base pairs), with a final extension of 72°C for 8 
minutes. PCR products were confirmed using agarose gel electrophoresis and purified using 
gel extraction (see sections 2.2.5 and 2.2.6).     
2.2.4 Circular polymerase extension cloning (CPEC) 
For plasmids constructed using CPEC (Fig 2.1), vectors and inserts were amplified by 
Phusion® High-Fidelity PCR master mix with HF Buffer (New England Biolabs) (using the 
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same conditions as described in section 2.2.3). CPEC reactions were carried out in total 
volumes of 50 µL containing 25 µL Phusion® High-Fidelity PCR master mix with HF Buffer, 
purified vector (200 ng) combined with purified insert at a 1:1 molar ratio. The thermo-
cycling conditions for CPEC reactions used an initial denaturation period of 30 seconds at 
98°C, followed by cycles of denaturation (98°C for 15 seconds), annealing (55°C for 30 
seconds), and extension (72°C for 25 seconds per 1000 base pairs) and a final extension of 
72°C  for 5 minutes. One cycle was performed for single insert CPEC, but for multiple inserts 
this was increased to 20 cycles. CPEC reaction product was used directly for transformation 
(4 µL CPEC product in 50 µL competent cells). Figure 2.1 is a schematic diagram showing 
the cloning of a single insert using CPEC. Primers used for insert and vector amplification 
are designed to overlap both the insert and vector, allowing the resultant PCR products to 
act as a template for each other in the final CPEC reaction.   
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Figure 2.1 Schematic diagram of circular polymerase extension cloning for single insertion 
Construct designed in silico with a primer pair at each intersection between vector and 
insert. Primer pair 1 and primer pair 2 used to amplify insert and vector respectively in 
separate PCR reactions using appropriate templates. Gel extracted and purified PCR 
products combined for CPEC reaction in which they act as templates for each other. Final 
constructs can are transformed into chemically competent cells for propagation.  
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2.2.5 Agarose gel electrophoresis  
DNA fragments were separated using agarose gel electrophoresis, carried out with 1% 
(w/v)  agarose (Sigma) dissolved in Tris-Borate-EDTA (TBE) (89 mM Tris-Borate, 2 mM 
EDTA) plus a 1 in 10,000 dilution of SYBR safe (Invitrogen). Gels were submerged in TBE 
running buffer within a horizontal electrophoresis tank (Thermo Fisher Scientific) and 
subjected to 100-120 volts for 45-90 minutes. DNA samples were prepared with 6X loading 
dye (Thermo Fisher Scientific), and HyperLadder 1kb (Bioline) was used as the DNA marker.    
2.2.6 Gel extraction 
DNA fragments were extracted from agarose gels and purified using a QIAquick Gel 
Extraction Kit (Qiagen), following the protocol provided.  
2.2.7 Plasmid isolation and purification  
Plasmids were isolated from single colonies and propagated in LB media (containing 
appropriate antibiotic). Plasmid DNA was then purified using a QIAprep Miniprep Kit 
(Qiagen) following the standard protocol.  
2.2.8 Chromosomal DNA preparation 
The genomic DNA from a number of microbial species was used for cloning within this 
study, some of which required preparation before being used as a PCR template. 
2.2.8.1 Saccharomyces diastaticus genomic DNA preparation 
Saccharomyces diastaticus was supplied as a slant by the University of Reading, and was 
subsequently re-streaked onto YPD agar plates and incubated at 30°C for 48 hours. A 
colony was then suspended in 20 µL of 0.25% (v/v) SDS, vortexed and centrifuged at 17000 
g for 5 minutes. The supernatant was diluted 1 in 50 for use in PCR.  
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2.2.8.2 Thermoanaerobacter tengcongensis genomic DNA preparation 
Thermoanaerobacter tengcongensis was supplied lyophilised by The Leibniz Institute DSMZ 
(DSM number 15242 Caldanaerobacter subterraneus subsp. tengcongesis), and was re-
suspended in 1 mL of 20% (w/v) glycerol. This stock was diluted 1 in 10 with sterile water. 
Lysozyme was added to this dilution to give a final concentration of 50 µg/mL and the 
mixture was incubated at 37°C for 15 minutes. SDS was then added to give a final 
concentration of 1% (v/v), turning the mixture clear and viscous. 250 µL of this solution was 
combined with a vortexed mixture of P2 (250 µL) and N3 (350 µL) reagents (QIAprep 
Miniprep Kit, Qiagen) and centrifuged for 10 minutes at 17000 g. The supernatant was 
loaded onto a spin column (QIAprep Miniprep Kit, Qiagen) with the standard miniprep 
protocol followed from this point onwards. The genomic DNA was eluted with 100 µL EB 
buffer, and used directly for PCR. 
2.2.8.3 Chromobacterium violaceum genomic DNA preparation    
Chromobacterium violaceum was supplied by J. Ward as a glycerol stock, from which 250 µL 
was processed as above (section 2.2.8.2).  
2.2.8.4 Deinococcus geothermalis genomic DNA preparation 
Deinococcus geothermalis was supplied by J. Ward as a glycerol stock and prepared into 
genomic DNA suitable for PCR by M. Bawn.        
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2.3 Growth media preparation 
2.3.1 Luria broth (LB) media  
Miller’s LB Broth (Sigma Aldrich), containing 10 g/L Tryptone, 10 g/L NaCl and 5 g/L yeast 
extract, was prepared by dissolving 25 g in 1 L of water. The media was autoclaved at 121°C 
for 15 minutes. 
2.3.2 Terrific broth (TB) media 
Terrific broth (Sigma Aldrich), containing 12 g/L Tryptone, 24 g/L yeast extract, 9.4 g/L 
K2HPO4, and 2.2 g/L KH2PO4, was prepared by dissolving 47.6 g plus an additional 8 mL of 
glycerol into 1 L of water, and was autoclaved at 121°C for 15 minutes.    
2.3.3 Glucose free mineral salt medium (MSM) 
Glucose free mineral salt medium (MSM) was adapted from Krause et al 2010 [82] and was 
prepared by dissolving (per L of water) 2.0 g Na2SO4, 6.12 g (NH4)2SO4, 0.50 g NH4Cl, 14.60 g 
K2HPO4, 3.60 g NaH2PO4·H2O, 1.00 g (NH4)2-H-citrate, 3 mM MgSO4, 0.1 g thiamine 
hydrochloride, and 2 mL of SM6 trace element solution (composed of 104 g/L Citric acid, 
5.22 g/L CaCl2.2H2O, 2.06 g/L ZnSO4.7H2O, 2.72 g/L MnSO4.4H2O, 0.81 g/L CuSO4.5H2O, 0.42 
g/L CoSO4.7H2O, 10.06 g/L FeCl3.6H2O, 0.03 g/L H3BO3, 0.02 g/L Na2MoO4.2H2O). The 
solution was filter sterilised using 0.22 µm Millipore ExpressTM PLUS stericup® with a 
vacuum pump. MSM was prepared in three formats, either glucose free MSM (see section 
2.3.4), MSM supplemented with 2.5 mg/mL glucose (Sigma), or MSM supplemented with 
2.5 mg/mL starch (soluble potato starch, Sigma). To assist with dissolving starch the latter 
required pre-autoclaved water containing enough starch for a final concentration of 2.5 
mg/mL prior to addition of the other constituents and filter sterilisation.   
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2.3.4 Starch-agar layer preparation  
Starch-agar layers were prepared within 500 mL baffled shake flasks, and were used in 
conjunction with glucose free MSM media. Firstly, a 50 mL solution of 50 mg/mL starch and 
2 mg/mL agar was added to the flask and autoclaved at 121°C for 15 minutes. Once cooled, 
50 mL of pre-autoclaved 50 mg/mL agar was poured on top of the original layer and 
allowed to cool. Finally, 50 mL of glucose free MSM was added to the flask as the liquid 
media, which is displaced by the solid starch-agar layers and remains predominantly above 
the layers within the flask.    
2.4 Growth and expression protocols  
2.4.1 Overnight cultures 
All growth and expression studies were inoculated with either a 1 in 20 dilution from an 
overnight culture, or inoculated to an initial OD600 of 0.1 or 0.25. Overnight cultures were 
generally 5 mL LB in a 50 mL falcon tube (containing appropriate antibiotic) seeded from a 
glycerol stock, and grown at 37°C at 250 rpm.     
2.4.2 Shake flasks 
Shake flask cultures generally followed a standard protocol with the exception of the 
EnPresso® growth system (see section 2.4.4). For growth and expression experiments, 
unless otherwise stated, 500 mL baffled conical shake flasks were used, containing 50 mL of 
selected media. In addition to media an antibiotic, if needed, was supplied at the following 
concentrations: kanamycin (20 µg/mL); ampicillin (50 µg/mL); chloramphenicol (30 µg/mL). 
For induction of all inducible promoters used in this study, 0.4 mM IPTG was added when 
the culture had reached an OD600 of 0.6-0.8, or at inoculation, for growth experiments 
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involving amylolytic strains. Shake flask cultures were carried out at varying temperatures 
and durations depending on the nature of the experiment (see individual experiment for 
detail), but all were performed in a standard orbital incubated shaker (innovaTM 4330, New 
Brunswick Scientific) at either 250 or 180 rpm.  
2.4.3 Automated experiments (microwell plates) 
Automation experiments used a Tecan Evo150 platform with integrated Eppendorf 
Thermomixer, Tecan Infinite M200 Pro plate reader and Hettich centrifuge. Set up required 
polypropylene 96-deep square well (96-DSW) culture plates, 96-standard round well (96-
SRW) plates, reagent troughs and disposable microconductive tips. A sterile environment 
was maintained by a Walker class 2 biosafety cabinet equipped with laminar flow and HEPA 
filtration system. Liquid handling steps were devised by F. Truscott, and implemented using 
Freedom EVOware® software. All experiments used a total culture volume of 800 µL per 
well (96-DSW), agitation at 800 rpm, and a temperature of 37°C over a period of 8 or 24 
hours depending on the experiment. Cell density was measured in 96-SRW plates using 
OD600, and, when required, GFP fluorescence intensity was measured using an excitation 
wavelength of 483 nm and an emission wavelength of 535 nm (Tecan Infinite M200 Pro).    
2.4.4 EnPresso® Growth System 
For shake flask growth using the EnPresso® growth system, the standard protocol 
developed by BioSilta was followed, with some alterations applied specifically to amylolytic 
strains. A pre-culture was grown from a glycerol stock (or a single colony from an agar 
plate) in 2 mL LB containing an appropriate antibiotic (see section 2.4.2 for concentrations) 
for 6-8 hours at 37°C, 250 rpm. This culture was then used as inoculum (a 1 in 25 dilution) 
and added to 50 mL sterile water in a 500 mL shake flask containing one white bag (of two 
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tablets composed of minerals, vitamins, trace elements, inorganic and organic nitrogen for 
pH control, and a polysaccharide substrate), the required antibiotic, and 25 µL of reagent A 
(containing amyloglucosidase) (for amylolytic strains reagent A was replaced with 0.4 mM 
IPTG). Cultures were incubated overnight for 15-18 hours at 30°C, 250 rpm. Further 
nutrients were added to the culture in the form of a booster tablet (composed of nutrients 
and polysaccharide substrate), along with IPTG for induction and a further 25 µL of reagent 
A (neither of which were added to flasks containing amylolytic strains). Cultures were 
incubated for an additional 24 hours at 30°C, 250 rpm before harvest. For the amylolytic 
strains the first culture period was at 37°C rather than 30°C and the second culture period 
following the addition of the booster tablet was 25°C rather than 30°C, in order to optimise 
the cell densities achieved.         
2.5 Protein expression studies 
2.5.1 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
The expression of heterologously expressed protein was analysed using SDS-PAGE. Either 
whole cell lysate or clarified lysate samples (see section 2.5.5) were mixed with NuPAGE® 
LDS sample buffer (4X) and incubated at 70°C for 10 minutes. They were subsequently 
centrifuged at 17000 g for 5 minutes and loaded onto NuPAGE® Bis-Tris Mini Gels (Novex) 
and run using 20X MOPS buffer (ThermoFisher Scientific) (50 mM MOPS, 50 mM Tris Base, 
0.1% SDS, 1 mM EDTA, pH 7.7) at 200 volts for 50 minutes. Gels were stained with 
InstantBlueTM (Sigma Aldrich) for 1 hour and de-stained with water for 12-24 hours on a 
rocker.   
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2.5.2 Amylase assay  
Amylase activity was determined by measuring the rate of degradation of starch-iodine 
complex, a method adjusted from Blanchin-Roland and Masson [83]. An appropriate 
dilution of sample from either the periplasmic or extracellular fraction was made up to 0.5 
mL with 15 mM sodium phosphate buffer (pH5.8). Unless otherwise stated this was 50 µL 
of sample in 450 µL sodium phosphate buffer. This dilution was then incubated to an assay 
temperature of 50°C for S. thermoviolaceus α-amylase, or 37°C for the glucoamylase 
enzymes. The reaction was initiated by the addition of 0.5 mL starch solution (5 mg/mL) 
made up in 15mM sodium phosphate buffer (pH5.8). Subsequent 50 µL samples were then 
taken at numerous time points and added to 1 mL of potassium iodide/iodine solution 
(freshly prepared by adding 200L 2.2%I2/4.4%KI (w/v) into 100mL of 2% (w/v) KI solution) 
with the corresponding decrease in absorbance at 600 nm measured. Unless otherwise 
stated one unit of enzyme activity for S. thermoviolaceus α-amylase is defined as the 
disappearance of 1 mg/mL of starch/iodine complex per minute at 50°C, and one unit of 
enzyme activity for the glucoamylase enzymes is defined as the disappearance of 1 mg/mL 
of starch-iodine complex per minute at 37°C.   
2.5.3 Determination of extracellular amylolytic enzyme activity  
For the determination of secreted amylolytic enzyme within the extracellular media, 1 mL 
of culture was centrifuged at 17000 g for 5 minutes with the resultant supernatant 
collected as the extracellular media fraction. To quantify activity from this fraction, samples 
were directly added to the amylase assay (section 2.5.2).       
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2.5.4 Periplasmic release procedure 
The following procedure was used for analytical scale periplasmic release. 1 mL of culture 
was centrifuged at 17000 g for 5 minutes. The resultant pellet was re-suspended in 200 µL 
of extraction buffer (20% (w/v) sucrose, 1 mM Na2EDTA, 200 mM Tris.HCL, 500 µg/mL 
lysozyme (Sigma)) and incubated at room temperature for 15 minutes. 200 µL of distilled 
water was then added and the mixture was incubated for a further 15 minutes before 
being centrifuged at 17000 g for 10 minutes. The supernatant was collected as the 
periplasmic fraction, with activity determined via direct addition to the amylase assay 
(section 2.5.2).   
2.5.5 Whole cell and clarified lysate preparation 
In expression studies and some activity assays, whole cell lysates and clarified cell lysates 
were measured. Samples (1 mL) of culture were centrifuged at 17000 g for 5 minutes. The 
resultant pellet was re-suspended in 300 µL phosphate buffered saline (PBS) (pH7.4) and 
sonicated (3 cycles of 20 seconds on, 20 seconds off with an amplitude of 10 microns, MSE 
Soniprep 150). The ensuing whole cell fraction was further centrifuged at 17000 g for 5 
minutes and the supernatant collected as the clarified lysate.   
2.5.6 Starch degradation assay 
Starch degradation within culture media was determined using an adaptation of the 
amylase assay, whereby a 50 µL sample of clarified culture media was added directly to 1 
mL of potassium iodide/iodine solution (freshly prepared by adding 200L 2.2%I2/4.4%KI 
(w/v) into 100mL of 2% (w/v) KI solution). The absorbance was measured against a 
potassium iodide/iodine solution blank at 600 nm, with a standard curve prepared to 
determine concentration. For concentrations of starch beyond the linear range of the 
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spectrophotometer the sample of clarified culture media was diluted appropriately and 
added to the potassium iodide/iodine solution in the same ratio.  
2.5.7 Glucose (GO) assay  
The Glucose (GO) assay kit (supplied by Sigma) was used as per the technical bulletin 
provided. Samples were diluted with deionised water to between 20 and 80 µg glucose per 
mL. Reactions were initiated following the addition of 2 mL of glucose oxidase/peroxidase 
reagent to 1 mL of sample, and incubated at 37°C for 30 minutes. The reaction was 
quenched by the addition of 2mL of 12 N H2SO4, and the subsequent absorbance was 
measured against a reagent blank at 540 nm. Glucose concentration was determined using 
a standard curve.   
2.5.8 Fluorescence measurements 
Fluorescence intensity of eGFP from samples of neat cell culture dispensed in either 24 or 
96 microwell plates, were measured using excitation and emission wavelengths of 483 nm 
and 535 nm respectively (Tecan Infinite M200 Pro). Gain was optimised for each 
experiment conducted. Fluorescence units were displayed either irrespective of cell 
density, or were normalised to OD600 depending on the specific experiment conducted.   
2.5.9 Ortho-nitrophenyl-β-D-galactopyranoside (ONPG) β-galactosidase assay 
Ortho-nitrophenyl-β-D-galactopyranoside (ONPG) is a colorimetric substrate for β-
galactosidase, allowing for the determination of β-galactosidase activity and subsequent 
inference of catabolite repression. Assays took place in a 96 microwell plate and involved 
the addition of 150 µL of substrate solution (3 mM ONPG, 10 mM MgCl2, and 0.1 mM 2-
mercaptoethanol in PBS) to 200 µL of sample clarified lysate. The mixture was incubated at 
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30°C for 30 minutes and then quenched with 5 µL of 1 M sodium carbonate. Absorbance 
was measured at 410 nm (Tecan Infinite M200 Pro), indicative of the amount of ONPG 
hydrolysis product ortho-nitrophenol present in the sample lysate. Units of β-galactosidase 
activity were defined as change in absorbance at 410 nm per minute, and were normalised 
to OD600.   
2.5.10 High performance anion exchange chromatography with pulsed 
amperometric detection (HPAEC-PAD) analysis  
HPAEC-PAD analysis was used to detect and quantitate mono- and small chain oligo-
saccharides resulting from the amylolytic hydrolysis of starch. Detection was carried out by 
injecting 25 µL samples into a Reagent-Free Ion Chromatography System (ICS 5000+, 
Dionex) equipped with a Dionex CarboPacTM PA100 anion exchange column (2 x 250 mm) 
fitted with a Dionex CarboPacTM PA100 guard column (2 x 50 mm), and an electrochemical 
detector system. Elution was carried out using a linear gradient of 100 mM NaOH at 0 
minutes, to 60 mM NaOH and 400 mM NaOAc at 18 minutes, followed by a step of 40 mM 
NaOH and 600 mM NaOAc for a further 2 minutes. The column was re-equilibrated for 5 
minutes with 100 mM NaOH. The flow rate remained at 0.25 mL min-1 with a system 
pressure of approximately 2500 psi. Data collection and analysis was performed with 
Chromeleon software version 7. 
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3 Starch as an alternative carbon source in E. coli 
fermentation 
3.1 Introduction  
Starch has the potential to offer a number of advantages over more traditionally used 
carbon sources in E. coli fermentations. Firstly from a sustainability perspective starch 
represents a huge source of biomass, much of which constitutes agricultural waste 
streams, for example potato pulp from the potato industry. Given the increasing 
importance of developing a renewable and sustainable biomass-based economy, the direct 
utilisation of starch by E. coli presents an opportunity to convert this source of naturally 
occurring biomass into useful products, possibly reducing the reliance on petroleum 
derived hydrocarbons. In fact in a recent study by Rosales-Colunga et al, an E. coli K12 
strain was engineered to express and secrete an α-amylase, a first step towards developing 
a microbial platform capable of using agro-industrial wastes to produce valuable 
compounds [56]. 
Starch may also serve a more general purpose by providing a means to tackle one of the 
root causes of overflow metabolism in batch fermentations. As a polysaccharide starch is 
understood to be metabolically inert to E. coli, and as such could conceivably be present in 
media without effecting growth or expression. If an E. coli strain engineered to degrade 
starch into utilisable carbon were to grow in such media, the strain would be able to self-
feed and depending on the rate of hydrolysis, mimic fed-batch fermentations which 
commonly use glucose as the feed carbon source. Furthermore, it is widely known that 
glucose leads to catabolite repression, affecting a number of commonly used promoters for 
expression e.g. the lac promoter. With carbon present in the form of starch rather than 
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glucose, this has the potential to alleviate catabolite repression and give an experimenter 
more options when designing expression systems.  
This Chapter will explore some of the properties and characteristics of using starch as a 
source of carbon for E. coli, and describes an α-amylase producing strain originally 
constructed at University College London, highlighting its increased capability of degrading 
starch compared to current strains in the literature, as well as its ability to grow using 
starch as a sole carbon source.  
3.2 Investigating catabolite repression in the presence of starch 
Using the ortho-nitrophenyl-β-D-galactopyranoside (ONPG) assay described in the 
materials and methods (section 2.5.9), the properties of starch as a potential catabolite 
repressor were investigated. Results from an initial single experimental run demonstrated 
that when E. coli W3110 was grown in LB containing 10 mg/mL starch combined with 10 
mg/mL lactose, β-galactosidase was expressed; whereas when W3110 was grown in LB 
containing 10 mg/mL glucose combined with 10 mg/mL lactose, β-galactosidase was not 
expressed (Fig 3.1a). It is widely known from literature that glucose represses the lac 
operon, significantly impacting an experimenter’s choice of promoter when designing an 
expression system in traditional media. This result suggests that catabolite repression is not 
exerted when starch, unlike glucose, is present in the media, and as such could allow for a 
more flexible approach in terms of promoter use within expression systems. 
The data also show a clear increase in the optical density obtained from the starch 
containing culture compared with the glucose containing culture (Fig 3.1b). This has been 
explored further in Fig 3.10. 
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Figure 3.1 Catabolite repression of soluble potato starch in comparison to glucose. 
Single experimental run for E. coli W3110 cultured in LB containing 10 mg/mL lactose for 24 
hours at 37°C, 250 rpm, supplemented with 10 mg/mL starch (grey) or 10 mg/mL glucose 
(black). a) Accumulation of ONPG hydrolysis product ortho-nitrophenol measured using 
absorbance at 410 nm (Tecan infinite 200 pro) and expressed as units of β-galactosidase 
activity (defined as change in absorbance at 410 nm per minute, normalised to OD600). b) 
Growth curves for each condition throughout the culture period. 
 
3.3 Utilisation of starch by E. coli via heterologous expression and 
secretion of an α-amylase from Streptomyces thermoviolaceus 
In order to utilise starch as a carbon source E. coli must first be engineered to hydrolyse it. 
Unpublished work carried out by C. French and J. Ward used an α-amylase from 
Streptomyces thermoviolaceus CUB74 [57] to investigate periplasmic leakage into the 
media by different K12 strains of E. coli. The enzyme itself is particularly active and trivial to 
assay, and was therefore a useful tool in determining relative enzyme concentration both 
inside and outside the periplasm. Periplasmic leakage of S. thermoviolaceus α-amylase has 
as a result been used as a basis for this current study, with amylolytic activity in the media 
being used to hydrolyse starch into a utilisable carbon source to sustain E. coli growth.     
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3.3.1 Expression of S. thermoviolaceus α-amylase 
The S. thermoviolaceus α-amylase has been expressed using the vector pQR187 (section 
1.5.2.2). Fig 3.2a shows a schematic diagram of the multiple cloning site of pQR187 
containing the 1383 bp S. thermoviolaceus α-amylase gene alongside the lac promoter (65 
bp upstream of the gene) and the cer stability fragment (1955 bp downstream of the gene). 
The 65 bp and 1955 bp sections flanking the gene are untranslated regions of genomic DNA 
which fell between the restriction sites (HindIII and PstI) used for the original cloning. When 
induced with 0.4 mM IPTG, colonies of E. coli W3110 harbouring pQR187 under the 
selection of 20 µg/mL kanamycin expressed and secreted α-amylase into the surrounding 
agar (Fig 3.2b). The agar contained 7.5 mg/mL soluble potato starch and was stained 
blue/purple with potassium iodide/iodine solution, with visible halos around each colony 
indicating starch hydrolysis.  
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Figure 3.2 pQR187 expression and the quantification of α-amylase activity 
a) Schematic diagram of pQR187 containing the S. thermoviolaceus derived α-amylase gene 
fragment (1383 bp) including untranslated regions upstream (65 bp) and downstream 
(1955 bp) of the gene, as well as the cer stability fragment (200 bp). b) E. coli W3110 
harbouring pQR187 cultured on LB-agar containing 7.5 mg/mL starch, 0.4 mM IPTG and 20 
µg/mL kanamycin following incubation at 37°C for 24 hours and subsequent addition of 
potassium iodide/iodine solution (see materials and methods). c) Amylase assay of the 
periplasmic fraction (circle) and extracellular media fraction (square) of W3110 harbouring 
pQR187 (induced with 0.4 mM IPTG at an OD600 of 0.6-0.8) cultured at 37°C, 250 rpm for 24 
hours, alongside amylase assay buffer (15 mM sodium phosphate buffer (pH5.8)) containing 
2.5 mg/mL starch serving as a negative control (triangle). Error bars represent standard 
deviation, n=3.   
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3.3.2 Quantification and the subcellular localisation of α-amylase expressed 
from pQR187 
To quantify α-amylase activity an assay measuring the rate of decrease of a coloured 
starch/iodine complex originally developed by Blanchin-Roland and Masson (1989) [83], 
and modified by C. French and J. Ward [59, 84], was refined in this study (section 2.5.2) to 
measure the subcellular localisation of α-amylase. E. coli W3110 harbouring pQR187 
cultured over 24 hours (induced with 0.4 mM IPTG at an OD600 of 0.6-0.8) was processed in 
triplicate to obtain periplasmic and extracellular fractions to demonstrate the robustness of 
the assay (Fig 3.2c). Both periplasmic and extracellular fractions showed a degradation of 
starch within the assay over time, as opposed to the 2.5 mg/mL starch only control. It is 
worth noting that due to the assay conditions the periplasmic fraction appeared to have a 
greater activity than the extracellular fraction; however this is a misrepresentation as the 
periplasmic fraction was concentrated approximately three fold due to the nature of the 
periplasmic extraction process (section 2.5.4). Figures 3.3a and 3.3b show the normalised 
activity of each fraction expressed as units per mL of culture volume (defined as the 
disappearance of 1 mg/mL of starch/iodine complex per minute at an assay temperature of 
50°C).   
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Figure 3.3 S. thermoviolaceus α-amylase activity in periplasmic and extracellular fractions 
over time 
E. coli W3110 harbouring pQR187 induced with 0.4 mM IPTG at inoculation and cultured at 
37°C, 250 rpm for 24 hours. a) α-amylase activity in the extracellular media throughout the 
culture period, expressed as units of α-amylase per mL of culture. b) α-amylase activity in 
the extracellular media (grey) compared with α-amylase activity in the periplasmic fraction 
(black) throughout the culture period, expressed as units of α-amylase activity per mL of 
culture. Error bars represent standard deviation, n=3.   
 
 
As expected the extracellular activity of α-amylase (i.e. secreted α-amylase mediated via 
the leakage of periplasmic contents) increased throughout the time course of the culture 
(Fig 3.3a). The same is true, but to a lesser extent, for periplasmic activity (Fig 3.3b). As a 
result there was an increasing divide between amylase secreted into the media and 
amylase remaining in the periplasm throughout the culture. One possible explanation for 
this is that the periplasmic space has a certain capacity and once that capacity has been 
reached, leakage becomes more apparent. For the purposes of this project though it is the 
increase in extracellular amylase activity which has the potential to be useful, particularly 
from the perspective of developing a self-feeding strategy; as cell mass increases, more 
amyloyltic activity in the media is required for an increased release of utilisable carbon, 
which is itself in turn required to sustain cell growth. 
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3.3.3 Effects of temperature on the relative activity of S. thermoviolaceus α-
amylase  
20 30 40 50 60 70
0
20
40
60
80
100
R
el
at
iv
e 
ac
tiv
ity
 (%
) 
Assay temperature (°C)
 
 
Figure 3.4 Relative enzyme activity of S. thermoviolaceus α-amylase over a range of 
temperatures  
S. thermoviolaceus α-amylase activity in the extracellular media for 24 hour cultures of E. 
coli W3110 harbouring pQR187 in LB (induced with 0.4 mM IPTG at an OD600 of 0.6-0.8), 
determined using amylase assays carried out at a range of temperatures (20°C to 70°C). 
Activity expressed as a percentage of the standard assay carried out at 50°C. Error bars 
represent standard deviation, n=3.  
 
As an enzyme derived from a thermophilic organism, the S. thermoviolaceus α-amylase is 
known to be active at high temperatures [57, 85]; in fact the idea behind its original cloning 
was to find amylases which were active at high temperatures for potential use in the starch 
industry. The assay used to determine activity in previous Figures was carried out at 50°C, 
largely to reduce the possibility of background activity from endogenous amylases, as these 
would be denatured at this temperature. However, for a true comparison with previously 
engineered amylolytic strains of E. coli, the activity of the enzyme at traditional culture 
temperatures was investigated. Fig 3.4 shows extracellular α-amylase activity relative to 
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50°C for temperatures ranging from 20°C to 70°C. The optimum appeared to be around 
50°C, although there was still considerable activity (approximately 50%) at 30°C. Despite S. 
thermoviolaceus α-amylase being a thermostable enzyme, its activity at the typical culture 
temperatures for E. coli growth remains high enough for it to be a useful enzyme for this 
particular application. Unlike the previous experiment investigating the relative activities of 
α-amylase in the periplasm and the extracellular media, the assays carried out in Fig 3.4 
used samples from cultures which were induced at an OD600 of 0.6 to 0.8, rather than at 
inoculation, as an attempt to optimise the amount of enzyme expressed. 
3.3.4 Starch degradation studies 
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Figure 3.5 Starch degradation by the  S. thermoviolaceus α-amylase secreting E.coli strain  
E. coli W3110 harbouring pQR187 cultured in LB containing 10 mg/mL starch. Inoculated 
with overnight culture (1 in 20 dilution) and induced from time point zero with 0.4 mM 
IPTG. Starch concentration measured from absorbance of starch/iodine complex at 600 nm, 
following addition of media sample to potassium iodide/iodine solution. Flasks were 
incubated at 37°C and shaken at 250 rpm, with samples extracted from media containing 
cells (grey) and media alone (black). Error bars represent standard deviation, n=3.  
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Knowing that S. thermoviolaceus α-amylase from pQR187 has considerable enzymatic 
activity in the media when expressed in E. coli W3110, it seemed pertinent to measure the 
rate of starch degradation within a culture set-up. Starch dissolved to a concentration of 10 
mg/mL in LB was degraded to undetectable levels (using the starch degradation assay) 
within 100 minutes of the cultures initiation (inoculum from an overnight culture from a 1 
in 20 dilution, induced with 0.4 mM IPTG at inoculation) (Fig 3.5). It is worth noting that the 
degradation of starch is likely due in some part to α-amylase being present in the overnight 
inoculum media. Despite the inoculum being uninduced, α-amylase expression on pQR187 
is controlled by the lac promoter which is known to be leaky, due to titration of the low 
levels of the lac promoter repressor protein [86]. However, even when taking this into 
account, compared to the degradation rate seen in previous studies [56], whereby similar 
levels of starch degradation took tens of hours rather than tens of minutes, the 
combination of W3110 and pQR187 makes for a much more potent amylolytic strain. Work 
by Rosales-Colunga et al designed their constructs to contain a positive feedback loop, 
where the secretion of an endogenous α-amylase was promoted by the hydrolysis products 
of that same enzyme, in an attempt to maximise secretion. What is clear is that pQR187, on 
an IPTG inducible promoter, expresses and secretes α-amylase with substantially higher 
activity in the surrounding media than has been seen in those previous attempts. As a basis 
for a microbial platform with the ability to convert agro-industrial wastes into useful 
compounds, this has significant advantages.     
3.3.5 Hydrolysis products of S. thermoviolaceus α-amylase 
The hydrolysis products of S. thermoviolaceus α-amylase were identified using high 
performance anion exchange chromatography (section 2.5.10). Fig 3.6 shows the results 
from amylase assays carried out (at 37°C) using samples from the extracellular media of 24 
hour (37°C, 250 rpm) W3110-pQR187 cultures. As the assay proceeded, the concentration 
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of starch within the assay decreased (Fig 3.6a); indicating α-amylase was present in the 
media. In the same sample, the concentration of both maltose and maltotriose increased 
(Fig3.6b). A chromatogram 80 minutes into the amylase assay (Fig 3.6c) clearly displays the 
presence of oligosaccharides up to approximately 20 glucose units, exemplifying the endo-
acting nature of this α-amylase. When chromatograms from each time point throughout 
the assay are super-imposed it becomes clear that the longer oligosaccharides decreased in 
concentration over time, whereas the shorter oligosaccharides (maltose to maltotetrose) 
increased in concentration (Fig 3.6d). This finding supports the initial characterisation of 
this enzyme [57], confirming that the predominant hydrolysis products are maltose, 
maltotriose and maltotetrose.  
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Figure 3.6 Analysis of hydrolysis products from secreted S.thermoviolaceus α-amylase 
S.thermoviolaceus α-amylase activity within the extracellular media from 24 hour cultures 
of E. coli W3110 harbouring pQR187, inoculated with a 1 in 20 dilution of overnight culture 
and induced at an OD600 of 0.6-0.8 with 0.4 mM IPTG, grown at 37°C, 250 rpm. a) Starch 
degradation throughout assay. b) Maltose (circle) and Maltotriose (triangle) accumulation 
throughout assay. c) Chromatogram of assay sample at 80 minutes, highlighting sequential 
peaks representing oligosaccharides increasing in length by single glucose units. d) 
Amalgamation of assay time points, 10 minutes (black), 20 minutes (brown), 80 minutes 
(pink) and 370 minutes (blue), indicating differing concentrations between longer 
oligosaccharides and shorter oligosaccharides. Error bars represent standard deviation, n=3 
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In the context of engineering an E. coli strain to hydrolyse starch into a utilisable carbon 
source, this work confirms that S. thermoviolaceus α-amylase is a promising enzyme. It is 
capable of being highly expressed from pQR187 in W3110, and in doing so it is secreted 
into the medium where it has access to its substrate. The hydrolysis of this substrate 
produces primarily short oligosaccharides which E. coli can naturally metabolise [13]. The 
next section examines how supplementing culture media with starch affects the growth 
characteristics of E. coli W3110 when expressing and secreting S. thermoviolaceus α-
amylase. 
3.3.6 The influence of starch on the growth characteristics of E. coli K12 
secreting α-amylase 
 
 
 
Figure 3.7 Growth of E. coli W3110 harbouring pQR187 in LB media supplemented with 
starch 
a) Growth curves for E. coli W3110 harbouring pQR187 in shake flasks over 8 hours at 37°C, 
250 rpm (induced at inoculation (OD600 of 0.1) with 0.4 mM IPTG) in either LB media only 
(circle), or LB media supplemented with either 10 mg/mL starch (square) or 10 mg/mL  
glucose (triangle). b) Overnight cell density for W3110 harbouring pQR187 in 96-well plate 
at 37°C, 800 rpm (induced at inoculation (OD600 of 0.1) with 0.4 mM IPTG) in LB media 
containing increasing concentrations of starch (square) or glucose (triangle). Error bars 
represent standard deviation, n=3.    
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E. coli W3110 expressing and secreting S.thermoviolaceus α-amylase was able to grow to 
higher cell densities over eight hours in LB supplemented with 10 mg/mL starch compared 
with just LB media alone (Fig 3.7a). This was a similar increase to that of cells grown in LB 
supplemented with an equivalent amount of glucose (10 mg/mL). As the concentration of 
starch (and glucose for reference) within the media was increased (up to 20 mg/mL), the 
density following a 24 hour culture in a microwell plate also increased (Fig 3.7b). The 
presence of starch in the media appeared to provide a benefit over LB alone in terms of 
achievable final density for cells expressing and secreting α-amylase, and this final density 
was similar to that seen with an equivalent amount of glucose. 
3.3.7 Investigating reduced expression through ribosome binding site 
modification 
From the perspective of using this enzyme as a method of slowly releasing utilisable carbon 
from starch, it is fairly clear that pQR187 as a construct leads to excessive secretion of α-
amylase into the extracellular space and the subsequent rapid degradation of starch in the 
medium. Following an attempt to modularise pQR187 through the removal of non-coding 
regions of DNA both upstream and downstream of the gene, and the replacement of the 
native ribosome binding site (RBS) with an E. coli Shine-Dalgarno consensus sequence (see 
Fig 3.8), α-amylase secretion was surprisingly reduced. This however provided an 
interesting opportunity to investigate the effects of decreased α-amylase secretion on 
growth in media containing starch.   
3.3.7.1 Modified vector primer design and construction 
The cloning strategy used restriction digestion and ligation, taking advantage of the HindIII 
and PstI sites used in the original construction (section 1.5.2.2). The forward primer 
(Forwardamy2.1) was designed with an overhang to include the new RBS and a HindIII site 
at the 5’ end. The reverse primer (Reverseamy2) was designed with an overhang to include 
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the PstI site immediately downstream of the stop codon, thus removing non coding regions 
of DNA both upstream and downstream of the gene present in the original pQR187 vector. 
The new RBS and spacer region incorporated into the forward primer followed a Shine-
Dalgarno consensus sequence and had been used successfully in previous expression 
studies within the group (D. Jackson, personal communication). Following PCR, which used 
the original pQR187 vector as a template for the α-amylase, the resultant product was 
purified and digested with HindIII/PstI, and was subsequently ligated to the similarly 
digested and purified pQR187 backbone. The new vector pQR1700 was confirmed by 
restriction digestion analysis and sequencing from the M13 primer sites. 
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Figure 3.8 Diagram of primer design for modified vector construction   
a) Nucleotide sequence displaying twenty base pairs 5’ of the start codon, for both the 
native RBS and the consensus Shine-Dalgarno sequence. b) Forward primer 
(Forwardamy2.1) designed to include modified ribosome binding site upstream of the start 
codon, and downstream of the HindIII restriction site. Reverse primer (Reverseamy2) 
designed to include PstI restriction site immediately downstream of the stop codon.  
 
 
 
Native-RBS 
Modified-RBS 
a 
b 
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3.3.7.2 Activity from modified vector and growth characteristics  
 
 
Figure 3.9 The reduction of secreted α-amylase from a modified construct and the effects 
on growth in LB media containing starch   
E. coli W3110 harbouring either pQR187 or pQR1700, cultured at 37°C, 250 rpm and 
induced with 0.4 mM IPTG at inoculation. a) α-amylase activity in the extracellular media 
throughout the culture period (24 hours) for pQR1700 (grey) or pQR187 (black), expressed 
as units of α-amylase per mL of culture. Error bars represent standard deviation, n=3. b) 
Growth curves from single experimental run for W3110 harbouring pQR1700 (grey) or 
pQR187 (black) cultured in LB (square) or LB supplemented with 10 mg/mL starch (circle).  
 
The vector modifications led to a significant decrease (approximately 10 fold) in secreted α-
amylase, at all time points within the culture, compared with the original pQR187 construct 
(Fig 3.9a). Despite a consensus sequence being used for the ribosome binding site, the 
combination of replacing the native RBS, decreasing the spacer length, and removing 
nucleotide bases upstream of the gene, appeared to significantly diminished α-amylase 
expression.  
Growth curves for E. coli W3110 harbouring pQR187 were consistent with previous data 
(Fig 3.7a) which showed an increase in cell density at 8 hours for cultures containing starch 
compared to cultures grown in LB media alone. Conversely, growth curves for W3110 
harbouring pQR1700 did not differ between LB and LB supplemented with starch. Together 
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this would suggest that the level of α-amylase expression associated with each construct 
may have influenced growth rate, but in a way not necessarily related to the presence of 
starch. It is already known that a plasmid, even if no expression is taking place, can increase 
the metabolic burden on a cell through expression of antibiotic resistance genes and copy 
number maintenance [87]. It is also known that heterologous expression of a recombinant 
protein from a plasmid can place a further and more pronounced metabolic burden on the 
host cell, detrimentally affecting growth rate and final cell density [88]. In addition, the 
protein in this case is targeted to the periplasm, which can cause crowding of the 
translocation machinery during overexpression, again leading to a burden on cell growth 
[89, 90]. Given that cells harbouring the reduced expression construct achieved higher final 
cell densities, it is not unreasonable to assume that the reduction in final cell density seen 
by W3110-pQR187 in LB media was related to the over expression of α-amylase. 
Interestingly, however, very little difference in growth was seen between the two 
constructs in LB supplemented with starch. One explanation could be that the provision of 
extra carbon, in either the form of starch or glucose, may in some way salvage the reduced 
growth seen as a result of overexpression. The modified vector appeared not to be 
subjected to detrimental growth in the first place, possibly explaining why there was no 
benefit in terms of growth when supplemented by starch. Importantly the data also 
suggest the reduced rate of starch degradation within W3110-pQR1700 cultures did not 
lead to higher cell densities compared to the pQR187 equivalent, indicating that for this 
particular experimental setup the rate at which utilisable carbon was provided to the 
culture was not important for cell growth.    
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3.4 The ability of E. coli to degrade starch without exogenous 
amylase expression 
From the literature it is known that E. coli express an endogenous amylase encoded by 
malS which is active in the periplasmic space [15, 91]. However, the role of this amylase is 
currently unclear, with mutants showing only a small disadvantage in terms of growth 
compared to wildtype when cultured on long maltodextrins [13]. As maltodextrins increase 
in length beyond approximately eight glucose units, the ability of E. coli to utilise them as a 
sole carbon source begins to diminish. To our knowledge, the ability of E. coli to degrade 
polymers as large as starch, without the addition of an exogenous enzyme, has not 
previously been reported.  
3.4.1 Variations in starch degradation by non-amylolytic strains  
 
Figure 3.10 Degradation of starch within LB media for both W3110 and BL21(DE3) E.coli 
cultures 
a) Growth curves for W3110 (square) and BL21(DE3) (circle) cultured in LB media (black) 
and LB media supplemented with 2.5 mg/mL starch (grey), at 37°C, 250 rpm over 24 hours 
(inoculated to an initial OD600 of 0.1 from an overnight culture). b) Starch degradation 
within W3110 (square) and BL21(DE3) (circle) cultures over 24 hours at 37°C, 250 rpm. 
Remaining starch concentration determined using starch degradation assay with 
absorbance of starch/iodine complex measured at 600 nm. Error bars represent standard 
deviation, n=3.   
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E. coli strains W3110 and BL21(DE3) have not previously been reported to degrade starch; 
however when grown in LB supplemented with 2.5 mg/mL starch both showed increased 
densities after 24 hours compared with LB alone (Fig 3.10a). One potential explanation for 
this is that the starch added was not 100% pure, smaller oligosaccharides may be present in 
the starch mix as a result of the manufacturing process. Some of these shorter 
oligosaccharides could conceivably be metabolised by non-amylolytic E. coli and lead to an 
enhancement of growth. W3110 appeared to benefit more in terms of growth by achieving 
a higher cell density with the addition of starch than BL21(DE3), with very little difference 
between the two in LB media alone (Fig 3.10a). This suggests an inherent difference 
between the two strains in their ability to metabolise oligosaccharides.  
When measuring starch concentration within the media throughout the culture period, 
both strains unexpectedly demonstrated starch degradation, however, the extent to which 
BL21(DE3) degraded starch was significantly greater than W3110, with over 1 mg/mL of 
degradation in the first 10 hours of the culture period. The ability of BL21(DE3) to degrade 
starch to such an extent has not been reported previously. Counter intuitively, it was 
BL21(DE3) that degraded starch to the greatest extent but it was W3110 which was 
enhanced the most in terms of growth. Presumably the degradation of starch did not 
necessarily result in the release of utilisable carbon. The limits of the starch degradation 
assay i.e. the inability of iodine to form a complex with shorter oligosaccharides, mean that 
oligosaccharides less than approximately 18 glucose units in length are not detected [92]. 
High performance anion chromatography analysis was also not conclusive, being negative 
for oligosaccharides up to the detection limit of approximately 20 glucose units in length 
(data not shown). Together this suggests that either the starch had been hydrolysed into 
small length oligosaccharides which BL21(DE3) had metabolised for something other than 
biomass, or that the starch had been hydrolysed into oligosaccharides of lengths which 
were difficult to detect using these particular techniques. Regardless, BL21(DE3) had the 
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ability to degrade starch without exogenous amylase expression, and both strains showed 
some enhancement in growth when starch was added to the media.      
3.4.2 Starch as a supplement to enhance heterologous expression in complex 
media   
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Figure 3.11 Heterologous protein expression following supplementation of LB media with 
either starch or glucose 
E. coli BL21(DE3) harbouring pQR1344 cultured in either LB media, LB supplemented with 
10 mg/mL starch, or LB supplemented with 10 mg/mL glucose, induced with 0.4 mM IPTG 
at an OD600 of 0.6-0.8, and incubated at 25°C, 250 rpm for 24 hours. Samples (1mL) from 
each culture dispensed into a 24 well plate (Thermo Fisher Scientific) and whole cell GFP 
fluorescence intensity measured (with an excitation wavelength of 483 nm, and an 
emission wavelength of 535 nm, Tecan infinite 200 pro), normalised to OD600 (OD600 values 
for LB alone 4.2 ±0.2; LB supplemented with starch 4.8 ±0.2; and LB supplemented with 
glucose 5.1 ±0.3). Error bars and values represent standard deviation, n=3.  
 
 
 
To assess whether the increase in biomass associated with starch supplements was  
mirrored by an increase in recombinant protein expression, pET29a with an eGFP [93] 
insert (pQR1344, supplied by D. Dobrijevic) was transformed into BL21(DE3) and cultures 
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were grown in either LB alone, LB containing 10 mg/mL starch, or LB containing 10 mg/mL 
glucose. Expression of eGFP measured by fluorescence intensity (excitation wavelength of 
483 nm and of emission wavelength 535 nm, Tecan infinite 200 pro) appeared to be similar 
in both normal LB and LB supplemented with 10 mg/mL starch, indicating there was no real 
advantage with using starch for recombinant protein expression, despite the slight increase 
in cell density (cultures in LB alone had an OD600 of 4.2 ±0.2 whereas those in LB 
supplemented with starch had an OD600 of 4.8 ±0.2). When an equivalent amount of 
glucose was added to LB, there was a significant reduction in expression; consistent with 
previous catabolite repression data (LB supplemented with glucose achieved an OD600 of 
5.1 ±0.3). Despite there being no enhancement, the data support the notion that starch 
itself does not have a detrimental effect on recombinant protein expression, and may offer 
advantages over the more traditionally used glucose particularly if cells are able to utilise it 
for growth.   
3.4.3 Amylolytic activity associated with E. coli BL21(DE3) is not localised to the 
extracellular media  
By routinely using the extracellular fraction of untransformed E. coli (either W3110 or 
BL21(DE3)) as a negative control within the amylase assay, it was already known that there 
was very little amylolytic activity within this fraction, suggesting that the endogenous 
enzyme responsible for starch degradation is not secreted but rather associated with the 
cell itself. To further investigate this, an experiment was devised whereby cultures of 
W3110 and BL21(DE3) were grown in LB media supplemented with 2.5 mg/mL starch for 4 
hours. At this point each culture was split in two, half filtered through a 0.22 µm filter 
(Millipore) to remove cells and half left unaltered. The concentration of starch in each was 
subsequently measured. The filtered and unfiltered cultures were incubated separately for 
another 4 hours at which point the remaining starch concentrations were again measured. 
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At 4 hours post inoculation when the culture was spilt, BL21(DE3) had degraded 
approximately 10% of the starch in the media (Fig 3.12). After 8 hours (4hours following the 
split) the culture had degraded another 30% whereas the filtered extracellular media had 
not altered. The disparity between the two conditions confirmed that starch was only 
degraded in the presence of BL21(DE3) cells i.e. there was no amylolytic activity present in 
the media alone suggesting the enzyme responsible was not secreted but rather the 
amylolytic activity was associated with the cell itself. This evidence suggests BL21(DE3) 
expresses an endogenous  amylolytic enzyme, presumably associated with the periplasmic 
space or outer membrane which is capable of hydrolysing starch, and this is not expressed 
to the same extent in the W3110 strain.  
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Figure 3.12 Differentiating amylolytic activity associated with E. coli BL21(DE3) between 
the cellular and extracellular space 
E. coli W3110 and BL21(DE3) inoculated (1 in 20 dilution from overnight culture) in LB 
supplemented with 2.5 mg/mL starch. Cultures grown for 4 hours at 37°C, 250 rpm (dark 
grey), and for a further 4 hours following filtering or non-filtering (light grey). Error bars 
represent standard deviation, n=3.  
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3.4.4 Starch degradation by whole cell E. coli BL21(DE3) in glucose free mineral 
salt medium 
 
Figure 3.13 Degradation and utilisation of starch by E. coli BL21(DE3) 
Starter cultures (1 mL) centrifuged and subsequently re-suspended in 5 mL of either LB 
supplemented with 2.5 mg/mL starch or glucose free MSM supplemented with 2.5 mg/mL 
starch, incubated at 37°C, 250 rpm for a further 14 hours. a) Change in OD600 of re-
suspended cells over the 14 hour culture period. b) Amount of starch (mg/mL) degraded in 
culture media (using starch degradation assay for residual starch measurements with 
concentration calculated from a standard curve) over the 14 hour culture period. Error bars 
represent standard deviation, n=3.    
 
To determine the extent to which untransformed E. coli may benefit in terms of growth 
from starch, and to further characterise the native amylolytic activity, a starter culture of 
BL21(DE3) was centrifuged and subsequently re-suspended in either fresh LB 
supplemented with 2.5 mg/mL starch, or glucose free mineral salt medium (MSM) (see 
section 2.3.3 for composition) supplemented with 2.5 mg/mL starch, and incubated for a 
further 14 hours at 37°C, 250 rpm. With starch as the sole carbon source (i.e. MSM 
supplemented with starch), re-suspended BL21(DE3) cells were unable to increase in 
density beyond that of the initial resuspension, whereas BL21(DE3) re-suspended in LB 
supplemented with starch, showed a significant increase in density (Fig 3.13a). In terms of 
residual starch remaining in the media after 14 hours, there was no starch degradation in 
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the MSM cultures, whereas over 1 mg/mL was degraded in LB cultures (Fig 3.13b), 
consistent with previous results (Fig 3.10). The results indicate BL21(DE3) was unable to 
degrade or utilise starch when present as a sole carbon source, but could degrade starch in 
the presence of other utilisable carbon sources.  
3.5 E. coli secreting S. thermoviolaceus α-amylase utilising starch as 
a sole carbon source 
Figure 3.14 End point analysis of growth in mineral salt media (MSM) supplemented with 
starch or glucose 
a) Cell density (OD600) of both untransformed (black) and pQR187 harbouring (grey) E. coli 
W3110 and BL21(DE3) cultured over a 24 hour period at 30°C 250 rpm, in glucose free 
MSM, supplemented with 2.5 mg/mL starch. b) W3110 and BL21(DE3) harbouring pQR187 
cultured over a 24 hour period in MSM supplemented with either 2.5 mg/mL starch (dark 
grey) or 2.5 mg/mL glucose (light grey). Error bars represent standard deviation, n=3.  
        
This study has provided evidence to suggest the addition of starch to LB media offers a 
benefit in terms of biomass not only for E. coli expressing S. thermoviolaceus α-amylase, 
but also provides a benefit for the two untransformed strains investigated. To determine 
whether the engineered strains have any advantage over the untransformed strains in the 
context of utilising starch as a carbon source, experiments were carried out in defined 
media where all carbon sources were accounted for. When grown on glucose free mineral 
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salt medium (MSM) supplemented with 2.5 mg/mL starch, only E. coli expressing and 
secreting S. thermoviolaceus α-amylase was able to grow (Fig 3.14a). The untransformed E. 
coli strains were unable to grow to a density much beyond the initial inoculum after 24 
hours of culture. The two E. coli strains expressing α-amylase were also grown on MSM 
supplemented with 2.5 mg/mL glucose, which appeared to be a superior source of carbon 
particularly for W3110 harbouring pQR187 (Fig 3.14b). The increased cell density seen with 
glucose over starch indicates that at these concentrations, the negative effects of overflow 
metabolism on growth brought about by excessive glucose concentrations were not an 
important factor. At this concentration E. coli’s preferred source of carbon, glucose, 
remained the most beneficial for growth.  
3.6 Discussion and Conclusions 
Although not widely thought of as a source of carbon in E. coli fermentation, starch has 
been identified in this study as a potential alternative to some of the more traditional 
carbon sources. When added as a supplement to complex media such as LB, starch appears 
to offer a significant advantage in terms of growth even for E. coli which has not been 
engineered to degrade it. In fact, this work has identified that E. coli, particularly 
BL21(DE3), is capable of degrading starch without the heterologous expression of an 
amylolytic enzyme. However, despite achieving higher cell densities in complex media 
supplemented with starch, BL21(DE3) is unable to grow when starch is used as a sole 
carbon source in defined media. Incidentally, alongside this inability to grow, degradation 
of starch seen in LB media is eliminated when cells are re-suspended in defined media 
containing starch as the sole carbon source. There is also a paradoxical relationship 
between the two E. coli strain’s ability to degrade starch, and their ability to benefit in 
terms of growth from the presence of starch. The reason for this remains unclear; although 
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W3110 does degrade starch, BL21(DE3) degrades starch more than ten-fold faster, 
however, it is W3110 that benefits the most in terms of growth from the addition of starch. 
The mechanism behind starch degradation by untransformed BL21(DE3) cells is associated 
with the cells themselves, as there is no amylolytic activity in the media once cells have 
been removed, however further investigation is required to determine the specific 
products of this degradation, and their eventual route through central metabolism.  
The amylolytic activity of E. coli strains can be greatly increased through the heterologous 
expression of S. thermoviolaceus α-amylase. E. coli W3110, when expressing and secreting 
S. thermoviolaceus α-amylase from pQR187, can degrade starch present in the media at a 
rate many times faster than that of other engineered strains in the literature [56]. This 
opens up an opportunity to use this engineered strain as the basis for a microbial platform 
to convert starch into valuable products. An increase in α-amylase activity in the media 
over time also shows this has the potential to be applied to a self-feeding system; as the 
culture proceeds, cell mass increases, expressing and secreting more α-amylase which in 
turn provides more utilisable carbon for cell mass. However, it has been clearly 
demonstrated that the rate of α-amylase activity in the media is far beyond that which 
would be required, even when using the vector with reduced expression. Furthermore, 
there is a complexity associated with an endo-acting amylase in terms of hydrolysis product 
profile. The fact that S. thermoviolaceus α-amylase does not produce E. coli’s preferred 
carbon source, glucose, in any sufficient quantity, but rather a mixture of oligosaccharides 
of varying size, complicates the development of a slow release system for utilisable carbon. 
As such the next Chapter focusses on the possibility of using an exo-acting amylolytic 
enzyme, or glucoamylase, for the purpose of simplifying the hydrolysis product profile and 
mimicking enzyme-based fed-batch systems currently in use.         
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Finally, it has been demonstrated that E. coli cells expressing and secreting S. 
thermoviolaceus α-amylase have the capability of using starch as a sole carbon source, and 
do not require the presence of any other form of carbon within the culture media. Unlike 
previous strains developed by others [56], the densities achieved by W3110 and BL21(DE3) 
expressing S. thermoviolaceus α-amylase in MSM containing starch are not far off densities 
achieved in glucose, and can rival those of complex media such as LB. One of the limitations 
identified in this study thus far has been the difficulty in dissolving high concentrations of 
starch within the culture media. It has also become clear that LB is only capable of 
sustaining growth to a certain density, despite the amount of carbon present. To test the 
hypothesis that starch can offer a growth advantage over glucose by way of avoiding or 
minimising overflow metabolism, higher concentrations of both starch and glucose are 
required, as well as a media containing necessary amounts of other nutrients essential for 
high density growth. This has been investigated in greater detail in Chapter 5.        
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4 Novel bacterial glucoamylase discovery and 
characterisation  
4.1 Introduction 
Glucoamylases offer a particular advantage over α-amylases with respect to developing an 
enzyme-based feeding strategy. In contrast to α-amylases, their primary hydrolysis product 
is glucose, rather than a mixture of oligosaccharides of varying length. This simplifies both 
prediction and measurement from the perspective of glucose release, and also provides E. 
coli with its preferential source of carbon. This Chapter aims to identify and characterise 
candidate glucoamylases which when expressed and secreted by E. coli, can release glucose 
and enable growth using starch as a sole carbon source.  
The characterisation of bacterial glucoamylases is surprisingly uncommon in the literature, 
with the vast majority of commercially available enzymes of this type derived and produced 
from fungal sources. One of the difficulties with using fungal enzymes is achieving 
successful heterologous expression within an E. coli host, owed in large part to the post-
translational modifications required. To this end, a bioinformatics approach has been 
applied to identify putative bacterial glucoamylases, with selected candidates cloned and 
subsequently expressed in E. coli for characterisation studies. Further studies have 
focussed on the suitability of these novel glucoamylases for self-secretion, and eventual 
application within an enzyme-based fed-batch fermentation system. 
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4.2 Cloning of fungal glucoamylases and expression attempts in E. 
coli 
The most well characterised glucoamylases, primarily because they are used extensively in 
industrial applications, are derived from fungal sources. In most cases they are produced 
using their native host; however, there are examples in the literature where fungal 
glucoamylases have been successfully expressed in E. coli. Two examples are investigated 
here, firstly a glucoamylase from Aspergillus niger, which is commonly used within the 
starch industry, and a glucoamylase from Saccharomyces diastaticus, which has previously 
been heterologously  expressed in E. coli [65].  
4.2.1 Expression of a glucoamylase derived from Aspergillus niger  
As described in the introduction the enzyme-based fed-batch fermentation system 
developed by BioSilta uses a glucoamylase derived from A. niger (E.C.3.2.1.3) [34]. It 
therefore seemed appropriate to use this as a starting point within this study. Owing to the 
fact that the A. niger gene encoding glucoamylase (GLAA) contains four introns [94], it was 
decided to synthesise the coding region of the gene rather than attempting to clone it. 
Using the Uniprot FASTA sequence (P69328) the amino acid sequence was codon optimised 
(http://www.bioinformatics.org/sms2/rev_trans.htmL) for E. coli, and reverse translated. 
The resulting sequence was sent to Eurofins Genomics for synthesis and returned within a 
sub-cloning vector (pEX-K4-niger_Gluc) (Fig 4.1). During synthesis NdeI and XhoI restriction 
sites were inserted to flank the gene 5’ and 3’ respectively. This allowed for a one step sub-
cloning strategy using restriction digestion and ligation. Both parent (pEX-K4-niger_Gluc) 
and recipient (pET29a) plasmids were digested with NdeI/XhoI, with subsequent gel 
extraction and purification of both insert and pET29a backbone. These were ligated 
together to form pET29a-niger_Gluc, designated pQR1701. Expression vector construction 
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was confirmed with restriction digestion and sequencing. Expression studies revealed 
neither a visible band on SDS page at the expected size (approximately 68kDa), nor any 
functional activity within the whole cell lysate (see Fig 4.3).  
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Figure 4.1 Diagram of synthesised A. niger glucoamylase gene in initial sub-cloning vector 
and in expression vector 
Synthesised A. niger glucoamylase gene from pEX-K4-niger_gluc digested with NdeI and 
XhoI, extracted, purified, and ligated to the backbone of NdeI/XhoI digested pET29a, 
forming pQR1701.  
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4.2.2 Cloning and expression of a glucoamylase derived from Saccharomyces 
diastaticus 
 
Figure 4.2 S. diastaticus glucoamylase genomic PCR and expression vector design 
a) Agarose gel electrophoresis of genomic PCR product using diast-Gluc primers, forming a 
band 2334bps in size. b) Diagram of final expression vector (pQR1702) following NdeI/XhoI 
digestion of purified PCR product and ligation with NdeI/XhoI digested and purified pET29a 
backbone. 
 
 
Unlike GLAA from A. niger, the glucoamylase STA1 derived from S. diastaticus has been 
cloned and expressed in E. coli previously [65]. Cloning directly from the S. diastaticus 
genome was therefore attempted (see section 2.2.8.1 for genomic DNA preparation) with 
the aim of inserting the gene into an expression vector. Primers were designed with 
overhanging regions to include NdeI upstream and XhoI downstream of the coding region. 
PCR (see section 2.2.3 for conditions) resulted in a band at 2334 bp (Fig 4.2a). This was 
extracted and purified for subsequent digestion with NdeI and XhoI restriction enzymes, 
and ligated to similarly digested and purified pET29a backbone, resulting in pET29a-
a b 
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diast_Gluc designated pQR1702 (Fig 4.2b). Confirmation of final construct was carried out 
by sequencing.  
Again, expression studies revealed no apparent band on SDS page at the expected size 
(approximately 83 kDa), as well as no functional activity within the whole cell lysate (Fig 
4.3). Functional activity data for both fungal enzymes is expressed as starch degradation 
rather than glucose accumulation, a method validated by using commercially available A. 
niger glucoamylase (E.C.3.2.1.3) (Sigma) as a positive control (data not shown). However 
glucose accumulation was also measured (Glucose GO assay kit, Sigma-Aldrich) and again 
neither enzyme showed activity (data not shown).  Owing to the rarity of heterologous 
expression of fungal glucoamylases in E. coli hosts, the two attempts here were not 
pursued any further. Instead attention was turned towards bacterial derived 
glucoamylases, in particular putative enzymes from organisms which were available in-
house.   
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Figure 4.3 Functional activity of whole cell lysates for E. coli expressing fungal enzymes  
Amylolytic activity of whole cell lysates from BL21(DE3) expressing either pQR1701 or 
pQR1702. Cultures grown for 24 hrs in LB at 30°C, 250 rpm (induced at OD600 of 0.6-0.8). 
Cells (1mL culture) were centrifuged for 5 minutes at 2000 g and re-suspended in 300 µL 
PBS for sonication (20 second on, 20 seconds off for 3 cycles). Cell lysates were added 
directly to the amylase assay with U of amylase activity defined as change in absorbance at 
600 nm of starch/iodine complex per minute. Error bars represent standard deviation, n=3.  
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4.3 Bioinformatics; identification and cloning of putative 
glucoamylases 
4.3.1 Identification of putative bacterial glucoamylase 
 
Figure 4.4 Phylogenetic tree of putative bacterial glucoamylases 
Putative bacterial glucoamylases cross referenced with organisms available in-house. 
Enzymes selected for initial screening (red) due to their relatedness to the previously 
characterised T. tengcongensis glucoamylase. Phylogenetic tree created using neighbour-
joining method by Molecular Evolutionary Genetics Analysis version 7.0 (MEGA7) software.  
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To identify putative glucoamylases the carbohydrate-active enzymes (CAZy) database [54] 
was used to search for bacterial enzymes classified as Glycoside Hydrolase Family 15, which 
includes glucoamylases (EC 3.2.1.3). Suitable enzymes were cross referenced with available 
organisms within the laboratory to form 17 potential cloning targets. Following a 
phylogenetic analysis using Molecular Evolutionary Genetics Analysis version 7.0 (MEGA7) 
software (Fig 4.4), which included a previously characterised enzyme (from 
Thermoanaerobacter tengcongensis) that had been successfully expressed in E. coli by 
another group [66], two other enzymes from Deinococcus geothermalis and 
Chromobacterium violaceum were selected for initial cloning and expression tests based on 
their relatedness to the T. tengcongensis glucoamylase.      
4.3.2 Classical restriction digestion and ligation cloning strategy 
 
Figure 4.5 Overview of cloning strategy for putative bacterial glucoamylases  
Cloning procedure for example putative bacterial glucoamylase (C. violaecium). Forward 
and reverse primers include NdeI and XhoI in their overhanging regions respectively. 
Following gel extraction and purification of PCR product, fragments are digested with NdeI 
and XhoI and are subsequently ligated to the pET29a backbone which has been similarly 
digested.   
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As above (in Fig 4.1 and 4.2), the cloning strategy used for these particular glucoamylases 
was classical restriction digestion and ligation. Primers for each of the putative 
glucoamylases were designed to include, within their overhanging regions, an NdeI 
restriction site immediately 5’ of the gene and an XhoI site immediately following the stop 
codon 3’ of the gene. These restriction sites allowed for insertion into the expression vector 
pET29a, in which the gene is regulated by the T7 promoter. See Figure 4.5 for an overview. 
4.3.3 PCR of target enzymes in selected organisms  
 
 
Figure 4.6 Agarose gel electrophoresis of D. geothermalis , T. tengcongensis, and C. 
violaecium genomic PCR 
Agarose gel electrophoresis results for genomic PCR of D. geothermalis, T. tengcongensis, 
and C. violaecium glucoamylase genes, using an annealing temperature gradient 5°C  either 
side of the lowest primer Tm. a) D. geothermalis (lanes 1-3), b) T. tengcongensis (lanes 4-6), 
and c) C. violaecium (lanes 7-9). d) Undigested (lane 10) and NdeI/XhoI digested (lane 11) 
pET29a.     
 
Genomic material from D. geothermalis, T. tengcongensis, and C. violaecium was extracted 
(see section 2.2.8 for genomic DNA preparation) and the respective glucoamylase genes 
were amplified using PCR under standard conditions (section 2.2.3). Using an annealing 
temperature gradient of 10°C (5°C either side of the lowest primer Tm) each PCR produced 
bands at the expected size; D. geothermalis (2396 bp), T. tengcongensis (2111 bp), and C. 
violaecium (2624 bp) (Fig 4.6). Following gel extraction and purification, DNA bands were 
b a c d 
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digested with NdeI and XhoI and ligated to purified NdeI/XhoI digested pET29a backbone. 
The resultant constructs, pQR1703, pQR1704 and pQR1705 respectively, were confirmed 
through restriction digestion analysis and sequencing.   
4.3.4 Construction of vectors incorporating histidine tags 
 
Figure 4.7 Diagram of pET28a expression cassette  
pET28a expression cassette highlighting the 6xHis tag upstream of the NdeI restriction site 
and downstream of the ATG start codon, allowing for a His-tag fusion to the N-terminus of 
genes cloned into NdeI/XhoI restriction sites. 
 
To allow for potential purification of these glucoamylases at a later stage it was appropriate 
to design a set of constructs whereby the new enzymes were fused to a histidine tag. As 
the previous primers were designed to include a stop codon between the gene and the 
XhoI restriction site, pET29a would not allow for inclusion of a His-tag to the C-terminus of 
the genes. Rather than redesigning the primers and repeating the PCRs, it was instead 
decided to attach a His-tag to the N-terminus of the genes by using the N-terminal His-tag 
of pET28a (Fig 4.7). This was advantageous as the same digested PCR products from the 
previous pET29a constructions could be used, given that the multiple cloning sites of 
pET28a and pET29a are identical. Cloning into pET28a therefore followed the same strategy 
as cloning into pET29a, with correct construction of the three vectors confirmed through 
sequencing. These were designated pQR1706, pQR1707 and pQR1708 for D. geothermalis, 
T. tengcongensis, and C. violaecium glucoamylases respectively.     
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4.4 Characterisation of D. geothermalis, T. tengcongensis and C. 
violaceum glucoamylases  
Following successful construction of the bacterial glucoamylase expression vectors, initial 
expression studies were carried out to determine whether a functional enzyme could be 
expressed within E. coli. 
4.4.1 Initial expression and cell lysate activity for selected glucoamylases 
Initially, following growth in LB for 24 hours at 30°C, 250 rpm (induced with 0.4 mM IPTG at 
an OD600 of 0.6-0.8), crude cell lysates of E. coli BL21(DE3) harbouring either pQR1703, 
pQR1704 or pQR1705 were run on SDS page (Fig 4.7a). This revealed a high level of 
expression for D. geothermalis glucoamylase, with a prominent band at 87.5 kDa. However 
there were no clear expression bands for T. tengcongensis or C. violaecium glucoamylases, 
which were expected to be situated at 79.1 kDa and 92.7 kDa respectively. Despite there 
not being any obvious expression using SDS page analysis, the clarified lysates were tested 
for amylolytic activity using the amylase assay described previously (section 2.5.2). In both 
cases, along with the D. geothermalis glucoamylase crude lysate, starch degradation was 
detected. Moreover, the starch degradation products were measured using an enzymatic 
glucose assay kit (Glucose GO assay kit, Sigma-Aldrich) with all three lysates displaying 
accumulation of glucose. In fact, when the enzymatically determined mass of starch and 
glucose were combined at an arbitrary time point within the assay (16 hours in this case), 
the total mass equalled the initial mass of starch (2.5 mg/mL) present at the beginning of 
the assay (Fig 4.7b). This indicated that the predominant hydrolysis product for all three 
enzymes was glucose, confirming their classification as exo-acting glucoamylases.   
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Figure 4.8 Glucoamylase expression and lysate activity  
a) SDS page analysis of crude lysates from overnight cultures of E. coli BL21(DE3) 
harbouring either pQR1703 (lane 2), pQR1704 (lane 3), or pQR1705 (lane 4), with BL21(DE3) 
as untransformed control (lane 1), inoculated with 0.4 mM IPTG at an OD of 0.6-0.8 and 
cultured in LB for 24 hours at 30°C, 250 rpm. Arrow indicates presence of D. geothermalis 
glucoamylase (87.5 kDa) (lane 2) b) Clarified lysate activity measured at a single time point 
during amylase assay (16hr) and displayed as amount (mg/mL) of remaining starch (dark 
grey) determined by absorbance of starch/iodine complex at 600nm, and amount (mg/mL) 
of glucose accumulated (light grey) determined by Glucose GO assay kit (Sigma-Aldrich).      
 
4.4.2 Further analysis of D. geothermalis, T. tengcongensis and C. violaceum 
glucoamylases 
With initial investigations confirming all three enzymes displayed glucoamylase activity, a 
more detailed approach was applied to identify any differences between the already 
characterised T. tengcongensis glucoamylase, and the two novel enzymes from D. 
geothermalis and C. violaceum. Furthermore, in an attempt to increase the expression of 
each enzyme, and increase the likelihood they would be present in the soluble fraction, the 
incubation temperature was lowered to 25°C and LB was replaced by terrific broth (TB).  
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4.4.2.1 Expression of D. geothermalis, T. tengcongensis and C. violaceum 
glucoamylases and their conversion of starch to glucose 
Both crude and clarified lysates of E. coli BL21(DE3) harbouring pQR1706, pQR1707, and 
pQR1708 (the pET28a based vectors) were run on SDS page (Fig 4.9a) following growth in 
terrific broth (TB) for 24 hours at a reduced culture temperature of 25°C (induction with 0.4 
mM IPTG at an OD600 of 0.8). As seen from initial expression studies the D. geothermalis 
glucoamylase crude lysate displayed a prominent band at 87.5 kDa, however there were no 
prominent bands in the clarified lysate sample, suggesting the majority of protein 
expressed was not soluble. Unlike initial expression studies the C. violaceum glucoamylase 
crude lysate under these conditions did contain a prominent band at 92.7 kDa, however 
again there were no noticeable bands in the clarified lysate. For the T. tengcongensis 
glucoamylase samples there were no obvious bands at the expected size (79.1 kDa) in 
either crude or clarified lysate. The clarified lysates for each enzyme were used in an 
amylase assay carried out at 37°C, from which samples were removed at specific time 
points and analysed for starch degradation and glucose accumulation (the latter 
determined using high performance anion exchange chromatography, section 2.5.10). 
Glucose accumulation measurements supported previous results determined 
enzymatically, showing that at an arbitrary time point within the amylase assay (1 hour in 
this case) the mass of starch remaining and the mass of glucose accumulated was more or 
less equal to the initial mass of starch at the beginning of the assay (2.5 mg/mL) (Fig 4.9b). 
It is worth noting at this point that cell densities were not normalised and expression levels 
were not the focus of the investigation, therefore the amount of starch 
degradation/glucose accumulation is not indicative of enzyme rate, as the amount of 
enzyme present was not known. One observation that can be made is that the combined 
mass of remaining starch and accumulated glucose for the T. tengcongensis enzyme was 
lower than for either of the two novel enzymes, coming in below the initial 2.5 mg/mL. The 
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logical conclusion is that the T. tengcongensis glucoamylase was converting a proportion of 
that starch into a different product, accounting for the negative value in the mass balance.    
       
 
 
 
Figure 4.9 Further expression studies and clarified lysate effects on starch degradation 
and glucose accumulation for D. geothermalis, T. tengcongensis and C. violaceum 
glucoamylases 
BL21(DE3) harbouring either pQR1706, pQR1707, or pQR1708, induced (0.4mM IPTG) at 
OD600 of 0.8 and grown in TB for 24 hours at 25°C. a) Crude (whole cell) and clarified lysates 
analysed on SDS page for each construct; D. geothermalis glucoamylase whole cell lysate 
(lane 1) and clarified lysate (lane 2), C. violaceum glucoamylase whole cell lysate (lane 3) 
and clarified lysate (lane 4), T. tengcongensis glucoamylase whole cell lysate (lane 5) and 
clarified lysate (lane 6). Arrows indicate the presence of D. geothermalis glucoamylase (87.5 
kDa) and C. violaceum glucoamylase (92.7 kDa) within the crude lysates (lanes 1 and 3 
respectively).  b) Clarified lysate activity measured at single time point during amylase assay 
(1hr) and displayed as amount (mg/mL) of remaining starch (dark grey) (starch degradation 
assay) and amount (mg/mL) of glucose accumulated (light grey)  (High performance anion 
exchange chromatography). Error bars represent standard deviation, n=3.        
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4.4.2.2 Hydrolysis products of D. geothermalis, T. tengcongensis and C. 
violaceum glucoamylases 
The chromatograms from the high performance anion exchange chromatography analysis 
of amylase assay samples at 1 hour for each clarified lysate show a clear difference in 
action between the T. tengcongensis enzyme and the two previously uncharacterised 
enzymes (Fig 4.10). The relatively small amount of glucose produced compared with other 
oligosaccharides suggests the T. tengcongensis glucoamylase had some endo-activity, 
whereas the D. geothermalis and C. violaceum glucoamylases produced more glucose 
relative to other oligosaccharides suggesting they had more pronounced exo-acting 
capabilities.  
 
 
 
 
 
 
 
 
 
 
 
 
99 
 
 
 
 
Figure 4.10 Chromatograms of D. geothermalis, T. tengcongensis and C. violaceum 
glucoamylase hydrolysis products 
Example ICS chromatograms for amylase assay samples removed after 1 hour, for clarified 
lysates of E. coli BL21(DE3) expressing a) pQR1706, b) pQR1707, and c) pQR1708, cultured 
in TB for 24 hours at 25°C, 180 rpm (induced with 0.4 mM IPTG at an OD600 of 0.8).  
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4.4.2.3 Clarified lysate activities for D. geothermalis, T. tengcongensis and C. 
violaceum glucoamylases 
Amylolytic activity from clarified lysate has also been expressed in terms of units of 
amylase activity per mL of culture (Fig 4.11a), with units, in this case, defined as the 
disappearance of 1 mg/mL of starch/iodine complex per minute at an assay temperature of 
37°C. Owing to the disparity in cell density between cultures amylase activity units have 
been normalised to dry cell weight (Fig 4.11b).  (BL21(DE3) expressing the T. tengcongensis 
glucoamylase consistently achieved lower cell densities than the other two enzymes, in 
both LB and TB. Example OD600 values from a single experimental run after 24 hours growth 
in TB at 25°C were as follows; OD600 of 10 for T. tengcongensis glucoamylase; OD600 of 33 
for D. geothermalis glucoamylase; and OD600 of 28 for C. violaceum glucoamylase) The 
normalised values indicate that despite an early observation that the D. geothermalis 
glucoamylase had higher expression levels compared with the other two enzymes, it is 
actually the C. violaceum glucoamylase which had the highest activity per gram of dry cell 
weight. When combined with glucose accumulation data (U defined as 1 mg/mL of glucose 
produced per minute at 37°C) normalised to dry cell weight (Fig 4.11c), the discrepancy 
between starch hydrolysis and glucose production for the T. tengcongensis glucoamylase is 
emphasised; further supporting the notion that the T.tengcongesis glucoamylase was not 
as exclusively exo-acting as the D. geothermalis and the C. violaceum glucoamylases. 
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Figure 4.11 Clarified lysate activities for D. geothermalis, T. tengcongensis and C. 
violaceum glucoamylases expressed in terms of starch degradation and glucose 
production 
a) Activity in units (disappearance of 1 mg/mL of starch/iodine complex per minute) per mL 
of culture. b) Activity in units (disappearance of 1 mg/mL of starch/iodine complex per 
minute) per gram of dry cell weight. c) Comparison in units of starch degradation (dark 
grey) (disappearance of 1 mg/mL of starch/iodine complex per minute) and glucose 
production (light grey) (accumulation of 1 mg/mL of glucose per minute) per gram of dry 
cell weight. Error bars represent standard deviation, n=3.  
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4.5 Investigating glucoamylase secretion 
Owing to the fact that the already characterised T. tengcongensis glucoamylase appears 
less desirable in terms of application than the two novel glucoamylases, no further work 
has involved the use of this enzyme. The next section investigates secretion of D. 
geothermalis and C. violaceum glucoamylases, using both native signal sequences and the 
fusion of exogenous signal sequences.     
4.5.1 Secretion of glucoamylases from native signal sequences 
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Figure 4.12 Extracellular media activity of D. geothermalis and C. violaceum 
glucoamylases 
Cultures of E. coli BL21(DE3) harbouring either pQR1703 or pQR1705 grown in LB media for 
24 hours at 37°C, 250 rpm and induced with 0.4 mM IPTG at an OD600 of 0.6-0.8. 
Glucoamylase activity within the extracellular media expressed as units (defined as the 
disappearance of 1 mg/mL of starch-iodine complex per minute) per mL of culture media. 
Error bars represent standard deviation, n=6.     
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The two novel glucoamylases were analysed using the SignalP 4.1 server [95] to determine 
whether the enzymes contained native signal sequences. Only the C. violaceum 
glucoamylase was positive for a signal sequence, a result confirmed experimentally when 
the extracellular media of E. coli BL21(DE3) harbouring each of the two glucoamylase 
constructs (pQR1703 and pQR1705) was measured for amylolytic activity. The C. violaceum 
glucoamylase culture (pQR1705) displayed significantly higher amylolytic activity in the 
extracellular media than the D. geothermalis culture (pQR1703) (Fig 4.12). Despite the 
latter not containing a native signal sequence, there was still detectable amylolytic activity 
within the extracellular media. This could conceivably be explained by small amounts of D. 
geothermalis glucamylase being released as a result of cell lysis during culture.     
4.5.2 Improvement of secretion through addition of signal sequences 
In an attempt to improve secretion for D. geothermalis and C. violaceum glucoamylases, a 
strategy was developed to insert new signal sequences at the N-terminus of each gene (Fig 
4.13). For the D. geothermalis glucoamylase the signal sequences selected were the DsbA 
signal sequence and the PelB signal sequence (section 1.6). Both of which were synthesised 
as complementary oligo nucleotides, with the 5’ end of the sense strand and the 3’ end of 
the antisense strand staggered to form a join compatible with an XbaI restriction site. The 
3’ end of the sense strand and the 5’ end of the antisense strand were designed to be 
staggered forming a join compatible with an NdeI restriction site. A ribosome binding site 
and a spacer region were included between the XbaI restriction site and the start codon. 
Following XbaI/NdeI digestion of pQR1703 the annealed oligo nucleotides were ligated 
forming pQR1703-DsbA and pQR1703-PelB, designated pQR1709 and pQR1710 
respectively. The addition of an alternative signal sequence to the C. violaceum 
glucoamylase was more complicated as the native sequence needed to be removed. To do 
this the enzyme was re-cloned using a forward primer which excluded the native signal 
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sequence but contained an NdeI site (including a start codon) in the overhanging region. 
The truncated gene was then cloned into pET29a forming pQR1711, whereby the same 
strategy as above could be applied. Only the DsbA signal sequence was used in this case, 
forming the vector pQR1712. 
Given that D. geothermalis glucoamylase did not contain a native signal sequence the initial 
lack of secretion was not unexpected. Surprisingly however, the addition of the DsbA signal 
sequence or the PelB signal sequence to the N-terminus of the gene did not improve 
secretion (Fig 4.14a). Furthermore, the clarified lysate activities of D. geothermalis 
glucoamylase containing additional signal sequences were reduced when compared to the 
native enzyme. The attempts to secrete the D. geothermalis glucoamylase with each type 
of signal peptide were unsuccessful, and actually appeared to have a negative impact on 
overall expression. Conversely, the addition of the DsbA signal sequence to the C. 
violaceum glucoamylase enhanced secretion (Fig 4.14b). Prior to addition, the removal of 
the native signal sequence reduced both extracellular media and clarified lysate activities, 
but these were rescued following addition of the DsbA signal sequence which displayed 
increased activity in the extracellular media compared with the native signal sequence. This 
was further enhanced when the activity was normalised to dry cell weight (Fig 4.14c). 
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Figure 4.13 Diagram of signal sequence insertion using complementary oligonucleotides  
Two oligonucleotides annealed to form the DsbA (a) and the PelB (b) signal sequence, plus 
an additional RBS and jagged ends complementary to an XbaI restriction site upstream and 
an NdeI restriction site downstream of the sequence. c) The location in to which the signal 
sequences are ligated, between the XbaI and NdeI sites within the original vector (d) 
(pQR1703 has been used as an example).  
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Figure 4.14 Activity of D. geothermalis and C. violaceum glucoamylases following addition 
of exogenous signal sequences 
E. coli BL21(DE3) harbouring  either a) pQR1703, pQR1709 (D. geothermalis glucoamylase 
with DsbA signal sequence) or pQR1710 (D. geothermalis glucoamylase with PelB signal 
sequence), or b) pQR1705, pQR1711 (truncated C. violaceum glucoamylase) or pQR1712 (C. 
violaceum glucoamylase with DsbA signal sequence), cultured for 24 hours in LB (induced 
with 0.4 mM IPTG at an OD600 of 0.6-0.8). Either extracellular media activity (dark grey) or 
clarified lysate activity (light grey) determined by amylase assay and expressed in units per 
mL of culture volume. c) Extracellular media activity of C. violaceum glucoamylase with 
native (pQR1705) or exogenous (pQR1712) signal sequence normalised to dry cell weight. 
Error bars represent standard deviation, n=6. 
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4.6 Growth characteristic of E. coli expressing and secreting C. 
violaceum glucoamylase 
Following the unsuccessful secretion attempts of D. geothermalis glucoamylase, the C. 
violaceum glucoamylase was identified as the most suitable candidate enzyme for use in a 
starch degrading, self-feeding E. coli strain. The following section describes the degradation 
of starch in culture conditions and the ability of E. coli expressing this enzyme to utilise 
starch as a sole carbon source. 
4.6.1 Effects of temperature on the relative activity of C. violaceum 
glucoamylase 
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Figure 4.15 Relative enzyme activity of C. violaceum glucoamylase over a range of 
temperatures 
Extracellular media activity from 24 hour cultures of E. coli BL21(DE3) harbouring pQR1705 
grown in LB (induced with 0.4 mM IPTG at an OD600 of 0.6-0.8), determined using amylase 
assays carried out at a range of temperatures (20°C to 60°C). Activity expressed as a 
percentage of the standard assay carried out at 37°C. Error bars represent standard 
deviation, n=3.  
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It is already known that C. violaceum glucoamylase can degrade starch at 37°C. Activity 
assays using extracellular media samples following an overnight culture were used to 
conduct an amylase assay at a range of temperatures in order to determine the relative 
activity, particularly at more typical E. coli culture temperatures of 25°C to 37°C. It was 
found that the optimum temperature for this enzyme was about 30°C (Fig 4.15), further 
emphasising its candidacy for the particular role to which it is being applied. 
4.6.2 E. coli secreting C. violaceum glucoamylase and its utilisation of starch as a 
sole carbon source 
 
 
 
Figure 4.16 E. coli’s utilisation of starch as a sole carbon source through the expression 
and secretion of C. violaceum glucoamylase  
E. coli BL21(DE3) harbouring either pQR1708 (native signal sequence) or pQR1712 (DsbA 
signal sequence) cultured over a 24 hour period at 30°C 250 rpm, in glucose free MSM, 
supplemented with 2.5 mg/mL starch. a) Cell density (OD600) after 24 hours of culture. b) 
Amount of starch degraded (mg/mL) in culture media after 24 hours of culture, determined 
by starch degradation assay. Error bars represent standard deviation, n=3. 
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or pQR1712 were cultured in glucose free MSM supplemented with 2.5 mg/mL starch, and 
resulted in similar cell densities as those previously seen with S. thermoviolaceus α-amylase 
(Fig 4.16a, refer to Fig 3.14 for α-amylase data). Cell density appeared to be correlated with 
the amount of starch degraded (Fig 4.16b), with the enhanced secretion of glucoamylase 
from pQR1712 showing greater starch degradation in the media and leading to a higher cell 
density. Unfortunately no data involving these constructs is available for W3110, owing to 
the fact they include a T7 promoter and are not inducible. The following Chapter explores 
in greater detail vectors designed specifically for the expression of C. violaceum 
glucamylase within W3110.     
4.7 Discussion and conclusion  
The A. niger glucoamylase was the initial target for recombinant expression within E. coli, 
given its prior use within an enzyme-based fed-batch fermentation system [34]. However, 
difficulties were encountered expressing this enzyme within E. coli, likely the reason why 
recombinant expression has not been reported previously. As a result other glucoamylases 
which have previously been successfully expressed in E. coli were investigated. The 
glucoamylase gene from S. diastaticus, which had been heterologously expressed in E. coli 
[65], was cloned from genomic DNA, however no functional expression was detected. An 
alternative approach was to investigate bacterial glucoamylases, based on the notion that 
E. coli is better equipped to express bacterial proteins than fungal proteins, particularly in 
the case of glucamylases which generally require complex post-translational modification 
[64]. A literature search revealed that there were surprisingly few bacterial glucoamylases 
which had been characterised, however, one was found from T. tengcongensis which had 
been successfully expressed in E. coli [66]. Using this previously characterised enzyme as a 
basis, a bioinformatics approach was used to identify enzymes with a similar homology 
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which were present in a library of organisms available in-house. Out of the 17 enzymes 
which matched the criteria, two putative glucoamylases from D. geothermalis and C. 
violaceum were the most closely related to the T. tengcongensis glucoamylase, and were 
therefore selected for cloning and characterisation.   
Characterisation studies revealed that the two novel enzymes were more exo-acting than 
the previously characterised T. tengcongensis glucoamylase, with high performance anion 
exchange chromatography data displaying an increased accumulation of glucose relative to 
longer chain oligosaccharides when the two novel glucoamylases hydrolysed starch. 
Furthermore, the mass balance of starch hydrolysis and glucose accumulation was less 
negative for both the D. geothermalis and the C. violaceum glucoamylases, than for the T. 
tengcongensis glucoamylase, suggesting an accumulation of product other than glucose for 
the latter enzyme.  
The ability of the D. geothermalis and the C. violaceum glucoamylases to be secreted into 
the extracellular media was also investigated. The C. violaceum glucoamylase contains a 
native signal sequence in contrast to the D. geothermalis glucoamylase, which was 
reflected in measured amylolytic activities in the respective extracellular media. The 
addition of exogenous signal sequences to the N-terminus of the D. geothermalis 
glucoamylase did not appear to improve secretion; however, the replacement of the native 
signal sequence from the C. violaceum glucoamylase with the DsbA signal sequence did 
improve secretion. The fact that the D. geothermalis glucoamylase does not contain a 
recognisable native signal sequence suggests it is not usually exported and therefore may 
not be the best candidate enzyme for an extracellular application.  Indeed, despite the 
addition of the DsbA signal sequence or the PelB signal sequence, no activity in the 
extracellular media was detected, suggesting that D. geothermalis glucoamylase is not 
easily secreted through either the SRP or Sec pathways. Conversely, the C. violaceum 
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glucoamylase is naturally secreted, and apparently capable of secretion by E. coli via both 
the native signal sequence and the exogenous DsbA signal sequence. 
Secreted C. violaceum glucoamylase via either signal peptide showed considerable glucose 
releasing amylolytic activity in the extracellular media, enough to allow expression strains 
to degrade starch contained within the medium during growth. Furthermore, E. coli 
BL21(DE3) expressing and secreting C. violaceum was able to utilise starch as a sole carbon 
source, which is to our knowledge the first example of E. coli converting starch directly to 
glucose for growth. The next Chapter describes the application of this as a novel feeding 
strategy to mimic fed-batch fermentation in batch cultures, and attempts to use the new 
chassis as a platform to increase yield of recombinant protein expression in shake flasks.   
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5 Towards a self-secreting enzyme-based fed-batch 
fermentation system 
5.1 Introduction 
Enzyme-based glucose limited fed-batch fermentation is an established technology which 
has been shown to enhance biomass and recombinant protein expression in lab scale 
cultures. However, to date there have been no successful attempts at designing a self-
contained enzyme-based fed-batch system using a cell engineering approach. Having 
already demonstrated the ability of amylolytic enzyme secreting E. coli strains to utilise 
starch as a carbon source, this Chapter explores the application of these strains as a means 
to increase cell mass over traditionally used complex media, and ultimately provide a basis 
for recombinant protein expression using starch as a substrate, which can outperform 
glucose in batch culture.  
As discussed, glucoamylases offer some advantages over α-amylases for this purpose, 
owing to their respective hydrolysis product profiles, with the slow release of glucose from 
the former mirroring both traditional fed-batch and current enzyme-based fed-batch 
fermentation strategies. As such, much of the work focusses on strains secreting the C. 
violaceum glucoamylase with the enhanced DsbA signal peptide. The regulation of 
amylolytic enzyme expression, in terms of both induction and rate of secretion throughout 
the culture, is also investigated, and involves the characterisation of a glucose sensitive 
promoter for the purpose of self-regulation. Finally, the ability of amylolytic self-secreting 
strains to provide a platform for recombinant protein expression using starch as a 
substrate, and ultimately achieving higher recombinant protein yield than is possible with 
glucose in batch culture, is examined using a combination of co- and dual-expression 
constructs.  
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5.1.1 Overview of Chapter 5 
This Chapter draws together components from the two previous Chapters in an attempt to 
examine in greater detail a cell engineering approach to enzyme-based fed-batch 
fermentation.  Given the multiple threads running throughout Chapter 5, the following 
overview provides a brief explanation and guide to its structure. 
The Chapter begins by examining the growth of an amylolytic E. coli strain within a 
commercially available enzyme-based fed-batch high cell density media, as a proof of 
concept for self-secretion leading to increased biomass. This follows on from conclusions 
made in Chapter 3 which suggested the concentrations of starch and glucose tested within 
LB was not high enough for overflow metabolism to be an important factor. For the 
purposes of these initial experiments the original α-amylase secreting strain, W3110 
harbouring pQR187, has been used (Figs 5.1 and 5.2).  
The commercially available media then provides a basis for the development of a defined 
media (MSM) containing starch-agar layers in an attempt to allow for the sufficient 
provision of carbon necessary for high cell density growth (Fig 5.3). Shake flasks containing 
starch-agar layers and glucose-free MSM are used for growth characterisation studies 
throughout the rest of the Chapter. Initially W3110 expressing and secreting α-amylase is 
cultured using starch-agar layers as a proof of principle (Fig 5.4). Further investigations are 
then carried out to determine if there are any potential differences in growth between 
W3110 and BL21(DE3) expressing and secreting α-amylase and whether starch can provide 
any advantage over more traditionally used glucose at these higher concentrations (Fig 
5.5). Incorporating some elements of Chapter 4, the growth of BL21(DE3) expressing and 
secreting C. violaceum glucoamylase with the exogenous DsbA signal sequence is then 
characterised using glucose free MSM with starch-agar layers (Fig 5.6).  
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Owing to the ability of the BL21(DE3) strain to be less susceptible to overflow metabolism 
than K12 strains, the next section focusses on the design and construction of vectors which 
contain promoters to allow for the expression of the C. violaceum glucoamylase  in W3110. 
Firstly, a glucose sensitive promoter is identified and subsequently characterised using 
eGFP as a reporter protein (pQR1714, Figs 5.7 and 5.8). A vector is then constructed from 
which the glucose sensitive promoter drives the expression of the C. violaceum 
glucoamylase containing the DsbA signal sequence (pQR1715, Fig 5.9), and is further 
characterised via extracellular glucoamylase activity following growth in LB containing 
various concentrations of glucose (Fig 5.10). Lastly this construct is used in growth 
experiments and starch degradation studies, in both LB (Fig 5.11) and glucose free MSM 
with starch-agar layers (Fig 5.12).    
The final part of the Chapter aims to establish whether the increased biomass achieved 
with the self-secreting amylolytic E. coli strains can be reflected by an increase in yield for a 
recombinant protein of interest. Firstly co-expression studies are carried out using α-
amylase and an E. coli derived transketolase as the protein of interest, cultured in both LB 
and the commercially available media used previously (Fig 5.13). Co-expression is then 
attempted in glucose free MSM containing starch-agar layers, using the glucose sensitive C. 
violaceum glucoamylase construct alongside the transketolase (Fig 5.14). An alternative 
approach is also investigated, involving the design and construction of dual-expression 
vectors i.e. where the amylolytic enzyme and the recombinant protein of interest are 
expressed from the same plasmid. Initially a pUC19 backbone is used to express α-amylase 
alongside eGFP as the protein of interest (Fig 5.15 and 5.16), with expression of each 
enzyme characterised in LB media (Fig 5.17) and later using starch as a sole carbon source 
in glucose free MSM (Fig 5.18). Finally a dual-expression vector is designed and constructed 
containing the C. violaceum glucoamylase with the attached DsbA signal sequence 
alongside eGFP as the protein of interest (pQR1720, Fig 5.19). This is characterised in 
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glucose free MSM containing starch-agar layers, providing the first demonstration of 
enhanced recombinant protein production as a direct result of self-secreting enzyme-based 
fed-batch fermentation (Fig 5.20).        
5.2 Expression and secretion of α-amylase within commercially 
available high density media 
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Figure 5.1 Growth curves of α-amylase secreting E. coli cultured in commercially available 
high cell density media 
E. coli W3110 (black) and W3110 harbouring pQR187 (grey) cultured as per the EnPresso® 
growth system protocol (see materials and methods, section 2.4.4). The untransformed 
control (W3110) required the addition of reagent A (externally supplied amylolytic 
enzyme), whereas W3110 harbouring pQR187 was cultured in the absence of reagent A 
and instead induced with 0.4 mM IPTG at inoculation. Error bars represent standard 
deviation, n=3.  
 
In media specifically designed for the slow release of glucose from starch, E. coli W3110 
expressing α-amylase was able to grow to considerably higher densities than non-
expressing W3110 (Fig 5.1). Both transformed and untransformed cells were grown 
according to the EnPresso® growth system protocol (see section 2.4.4), with the only 
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exception being that the α-amylase expressing strain did not require the addition of 
reagent A (a glucoamylase derived from A. niger), whereas the non-expressing control did 
require the addition of reagent A (i.e. starch degradation in cultures containing expressing 
cells was due to the self-secretion of α-amylase, but in cultures containing the non-
expressing control, starch degradation was the result of externally supplied A. niger 
glucoamylase). The enhanced growth seen by W3110 expressing α-amylase over the 
externally supplied enzyme control not only establishes a proof of concept for self-
secretion, but also highlights the potential in using a self-secreting strain to achieve cell 
densities in excess of those which can be achieved using current commercially available 
systems. 
 Consistent with previous results when W3110 harbouring pQR187 was grown in LB media 
(Fig 3.3), the expression levels of α-amylase increased throughout the EnPresso® culture 
period, as is seen from samples of clarified lysate analysed by SDS page (Fig 5.2a) i.e. 
qualitatively there was a more prominent α-amylase band (47 kDa) at 32 hours post 
booster addition than at 2 hours post booster addition. An increase in activity over time 
within the extracellular media was also observed (Fig 5.2b). As expected, there was an 
overall increase in activity within the extracellular media when normalised to cell density 
(dry cell weight) throughout the culture (Fig 5.2c). However, activity initially decreased, 
before increasing again, presumably because growth rate exceeded the rate of α-amylase 
expression when the booster was first added.  
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Figure 5.2 α-amylase expression over time in commercially available high density media 
E. coli W3110 harbouring pQR187 grown as per the EnPresso® growth system protocol, 
induced at inoculation (0.4 mM IPTG) and excluding the additional reagent A. a) SDS page 
of clarified lysate at time points post induction. (*) indicates a repetition of the 2 hour time 
point. Arrow indicates s. thermoviolaceus α-amylase (47 kDa). Extracellular media activity 
determined by amylase assay and expressed in units of α-amylase activity per mL of culture 
volume (b) or units of α-amylase activity normalised to dry cell weight (c). Error bars 
represent standard deviation, n=3.    
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5.3 Starch-agar layer development for sufficient provision of 
carbon 
Initial experiments described in Chapter 3 (Fig 3.7b and Fig 3.14b) indicated the amount of 
glucose added to the media (LB or MSM) thus far had not been large enough to have had 
any detrimental effects on growth i.e. the control groups containing an equivalent amount 
of glucose revealed that up to 20 mg/mL glucose did not have a negative influence on 
growth (albeit in microwell plate conditions), presumably meaning that overflow 
metabolism was not an important factor at this concentration in these conditions. 
Investigating growth in media with glucose concentrations beyond 20 mg/mL is fairly trivial, 
but dissolving starch at higher concentrations is particularly challenging. Given the difficulty 
of dissolving starch at concentrations in excess of 20 mg/mL, a commercially available 
media (EnPresso® growth system), in which starch is added in tablet form and dissolved 
into the media over time, was used as a proof of concept for achieving high densities with 
self-secreting cells (Fig 5.1). However, the exact composition of this media has been 
difficult to determine, a situation which necessitated the development of a high density 
media that is both defined and has the capacity to contain starch in a large enough quantity 
to support high density growth. As a result a previously established starch layer system [34] 
was modified to allow for sufficient release of starch into a liquid phase comprised of 
glucose free mineral salt medium (MSM) in 500 mL shake flasks (Fig 5.3). The process 
involved dissolving starch (using an autoclave) at a concentration of 50 mg/mL into 50 mL 
of 20 mg/mL agar, which once solidified was then capped with a 50 mL 50 mg/mL agar 
layer, preventing mechanical disruption by the liquid media above. Starch was then able to 
dissolve into the liquid media by diffusion throughout the culture period. Preliminary 
experiments revealed the actual method of starch diffusion was less reliant on the 
composition or size of the agar cap (contradicting the study in which the system was 
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developed, which itself suggested the agar percentage and thickness of the cap were 
important factors), but influenced to a greater extent by contact between the liquid media 
and the starch-agar layer via the sides of the flask. Although the starch-agar layer loses 
contact with the sides and bottom of the flask, allowing for mixing between the two 
phases, the conical shape of the flask prevents the agar cap from rising and therefore keeps 
the starch-agar layer beneath the liquid layer. At these specified concentrations the starch 
layer can theoretically provide up to 2.5 g of starch per flask. Fig 5.3c gives an indication of 
the diffusion of starch from the storage gel into the liquid media throughout the culture 
period, without the presence of cells. Within 24 hours, diffusion led to starch 
concentrations of over 10 mg/mL in the liquid phase.  
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Figure 5.3 Design of starch-agar layer system for sufficient provision of carbon for high 
cell density applications 
Photograph (a) and diagram (b) of the starch-agar layer design containing as a bottom layer 
50 mL of 50 mg/mL starch and 20 mg/mL agar. Above this an agar cap consisting of 50 mL 
of 50 mg/mL agar and a top layer of liquid media (glucose free MSM). c) Diffusion of starch 
from the starch-agar layer into the liquid media from flasks containing no cells measured by 
starch degradation assay of liquid media samples over time with concentration calculated 
using a standard curve. Error bars represent standard deviation, n=3.    
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5.3.1 Growth studies using starch-agar layers and E. coli secreting S. 
thermoviolaceus α-amylase 
E. coli W3110 expressing S. thermoviolaceus α-amylase was able to grow in flasks 
containing glucose free MSM with starch-agar layers, whereas non-expressing cells were 
unable to grow beyond initial inoculum densities (Fig 5.4). This mirrors previous results 
showing W3110 expressing α-amylase was able to utilise starch as a sole carbon source (Fig 
3.14a). Moreover, these results go further by indicating W3110 expressing α-amylase can 
achieve higher cell densities than are generally seen with LB when a sufficient amount of 
starch is supplied within glucose free MSM.  
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Figure 5.4 Increased cell densities for E. coli W3110 expressing S. thermoviolaceus α-
amylase using the starch-agar layer system 
Final cell densities for either untransformed E. coli W3110 or W3110 harbouring pQR187 
grown in flasks containing the starch-agar layer system and glucose free MSM, incubated at 
30°C,  180 rpm for 24 hours (induced with 0.4 mM IPTG at inoculation (inoculum equivalent 
to an initial OD600 of 0.1)). Error bars represent standard deviation, n=3. 
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To determine whether or not growth on starch offers any advantage in terms of final cell 
density compared with growth on glucose, an equivalent amount of glucose (50 mg/mL) 
was dissolved in MSM. Cultures of E. coli W3110 or BL21(DE3) expressing α-amylase were 
grown in flasks containing either MSM supplemented with glucose (50 mg/mL) or glucose 
free MSM with starch-agar layers. It is apparent that the increased concentration of 
glucose did have a detrimental effect on final cell density for the K12 strain, with cultures 
achieving densities approximately half that of cultures grown on starch (Fig 5.5). However, 
for BL21(DE3) there appeared to be no advantage when replacing glucose with starch. To 
some extent this supports the literature which suggests BL21 strains are more tolerant to 
excessive concentrations of glucose and are less affected by overflow metabolism [51].  
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Figure 5.5 Comparison of amylolytic strain growth on high concentrations of starch or 
glucose in MSM 
An end point analysis of E. coli W3110 or BL21 harbouring pQR187 cultured in flasks 
containing glucose free MSM with starch-agar layers (light grey) or MSM supplemented 
with 50 mg/mL glucose (dark grey) for 24 hours at 30°C, 180 rpm (induced with 0.4 mM 
IPTG at inoculation (inoculum equivalent to an initial OD600 of 0.1)). Error bars represent 
standard deviation, n=3.   
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5.3.2 Growth studies using starch-agar layers with E. coli secreting C. violaceum 
glucoamylase 
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Figure 5.6 Growth curves for E.coli expressing C. violaceum glucoamylase  
Growth curves in duplicate for E. coli BL21(DE3) harbouring pQR1712 cultured in MSM 
containing starch-agar layers (circle) or MSM supplemented with 50 mg/mL glucose 
(square) (induced with 0.4 mM IPTG at inoculation (inoculum equivalent to an initial OD600 
of 0.1)).  
        
As seen previously, secreted S. thermoviolaceus α-amylase has high activity in the 
extracellular media, meaning rapid degradation of available starch and a complex product 
profile (Figs 3.5 and 3.6). Furthermore, glucose, the most advantageous carbon source in 
terms of growth for E. coli, is not produced in any sufficient quantity. To mimic traditional 
fed-batch fermentation systems, and indeed commercially available enzyme-based fed-
batch fermentation systems, a glucoamylase from C. violaceum has been cloned into E. coli 
for subsequent expression and secretion within the glucose free MSM starch-agar layer 
setup. It has already been established in Chapter 4 that BL21(DE3) expressing and secreting 
C. violaceum glucoamylase can grow on starch as a sole carbon source (Fig 4.16). When 
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cultured using glucose free MSM in shake flasks containing starch-agar layers, BL21(DE3) 
secreting C. violaceum glucoamylase achieved densities beyond those typically seen in LB 
(Fig 5.6). However, once again growth on starch for BL21(DE3) secreting glucoamylase 
appeared to offer no advantage over glucose in terms of final cell density. In fact, glucose 
may have even led to higher cell densities than starch. More experimental repeats would 
be required to differentiate between the two but given that the results are consistent with 
previous observations in both this study and in previous literature, it was not investigated 
any further. 
5.4 Regulation of C. violaceum glucoamylase expression 
As seen previously, amylolytic expression strains of E. coli BL21(DE3) exhibited no growth 
advantage when supplemented with starch instead of glucose (Fig 5.6). This is true even at 
high concentrations of glucose. Conversely, E. coli W3110 secreting α-amylase has already 
demonstrated a 2 fold increase in cell density when grown on 50 mg/mL starch over an 
equivalent amount of glucose. The construction method for all C. violaceum glucoamylase 
vectors to date have used pET derived backbones, which contain the T7 promoter, 
inducible in BL21(DE3) but not in W3110. A K12 compatible promotor was therefore 
required for expression studies using W3110. Ideally this promoter would also provide the 
added benefit of being self-regulating rather than requiring induction, an important aspect 
from the perspective of enzyme-based fed-batch fermentation (see section 1.7 for details). 
5.4.1 Cyclic AMP dependant promoter  
The promoter, PcstA, characterised by the Edinburgh 2008 iGEM team, was selected as a 
candidate promoter for self-regulation based on its sensitivity to glucose concentration. To 
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characterise the promoter, eGFP was used as a reporter gene, with fluorescence measured 
at varying glucose concentrations within LB media.    
5.4.2 Vector design and characterisation of PcstA  
Using Biobrick Standard Assembly, eGFP was incorporated into BBa-K118011 (supplied by 
the 2016 iGEM distribution kit), to allow for PcstA to be characterised based on 
fluorescence. eGFP was cloned from pQR1344 using a forward primer with an overhanging 
region containing an XbaI restriction site upstream of an RBS site, and a reverse primer 
with an overhanging region containing a PstI site downstream of an SpeI site. Following PCR 
purification and subsequent digestion of the fragment with XbaI and PstI, the insert was 
ligated to a purified SpeI/PstI digested BBa_K118011 backbone, resulting in BBa_K118011-
eGFP, designated pQR1714 (Fig 5.7). 
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Figure 5.7 A schematic diagram of the Biobrick standard assembly method for suffix 
insertion 
The insert fragment containing an RBS upstream of the eGFP gene was amplified using PCR 
primers with overhangs specific to the Biobrick prefix and suffix (containing an XbaI 
restriction site, and both SpeI and PstI sites respectively). The PCR product was purified and 
digested with XbaI and PstI. The vector, BBa_K118011 containing the PcstA promoter, was 
digested with SpeI and PstI and both were ligated together to form pQR1714.  
  
 
127 
 
0 5 10 15 20
12500
15000
17500
20000
22500
25000
27500
G
FP
-F
U
/O
D
60
0
LB Glucose concentration (mM)
 
 
Figure 5.8 Characterisation of PcstA over a range of glucose concentrations using eGFP 
fluorescence  
E. coli W3110 harbouring pQR1714 grown in LB overnight and used to inoculate (with a 1 in 
20 dilution) LB supplemented with a range of glucose concentrations within a 96-well plate. 
Cultured for 8 hours at 37°C, 800 rpm. eGFP fluorescence intensity of neat whole cell 
samples was measured) with an excitation wavelength of 483 nm, and an emission 
wavelength of 535 nm (Tecan infinite 200 pro). Fluorescence units were normalised to 
OD600. Error bars represent standard deviation, n=3.  
 
E. coli W3110 harbouring pQR1714 was grown in LB overnight and was used to inoculate 
(with a 1 in 20 dilution) a 96-well plate containing LB with varying concentrations of glucose 
(0-20 mM). Following 8 hours incubation at 37°C the whole cell eGFP fluorescence was 
measured. eGFP fluorescence (fluorescence units normalised to OD600) decreased with 
glucose concentration from 0-5 mM (Fig 5.8), indicating that as glucose concentration 
increased, eGFP expression decreased. It is worth noting that because the inoculum was 
grown in LB containing no additional glucose, each well initially contained cells expressing 
eGFP, accounting for the background fluorescence seen in Fig 5.8. The result supports 
previous characterisation of PcstA, in which the promotor was found to be sensitive to 
glucose at concentrations between 0 and 10 mM in LB.  
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5.4.3 PcstA regulation of C. violaceum glucoamylase  
The characterisation of PcstA using eGFP has confirmed sensitivity to glucose within a 
concentration range applicable to glucose limited fed-batch fermentation i.e. glucose at a 
concentration of 5 mM is equivalent to 0.9 g/L, with typical values in the literature for 
direct feedback control mechanisms maintaining glucose concentrations to between 0.5 
and 2 g/L [22, 96, 97]. To establish whether the expression level is high enough for effective 
secretion of an amylolytic enzyme, the C. violaecum glucamylase containing the enhanced 
signal sequence (DsbA) was incorporated into the BBa_K118011 backbone producing 
pQR1715 (Fig 5.9).   
5.4.3.1 Vector design 
The Biobrick Standard Assembly method as previously described was not used to create 
pQR1715, owing to the presence of an internal PstI site within the C. violaceum 
glucoamylase gene. Instead, primers were designed to replace the PstI site with a BamHI 
site in the BBa_K118011 backbone. The forward primer (K118011BamHI.fw) was 
complementary to the sequence immediately downstream of the PstI site and included in 
the overhanging region the BamHI site. The reverse primer (K118011BamHI.rv) was 
complementary to the sequence immediately upstream of the PstI site. The PCR product 
was gel extracted, purified, and digested with SpeI and BamHI. Primers were designed to 
amplify the C. violaceum glucoamylase gene from pQR1712. The forward primer 
(K118011_CV2DsbA.fw) was complementary to the 5’ end of the gene and the region 
upstream of the start codon, including the RBS, spacer and XbaI site present in pQR1712. 
The reverse primer (K118011_CV1.rv) was complementary to the C-terminus of the gene 
(including the stop codon) and contained within the overhanging region a BamHI site. The 
PCR product was gel extracted, purified, and digested with XbaI and BamHI. The fragment 
was ligated to the K118011-BamHI backbone, with SpeI and XbaI sites combining to form a 
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scar (which cannot be digested by either original enzyme) between the PcstA promoter and 
the gene, and the two BamHI sites combining downstream of the gene.  
 
Figure 5.9 Schematic diagram for the insertion of C. violaceum glucoamylase gene into 
the BBa_K118011 backbone 
Primers were designed to replace the PstI (P) restriction site in the original BBa_K118011 
vector with a BamHI (B) site. Following PCR, the purified product was digested with SpeI (S) 
and BamHI (B) and ligated to the amplified rbs-CV2DsbA fragment containing an XbaI (X) 
upstream and a BamHI (B) site downstream, forming the construct pQR1715.    
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5.4.3.2 Characterisation of PcstA regulated C. violaceum glucoamylase secretion 
To ensure PcstA allows for expression and secretion of C. violaceum glucoamylase, 
amylolytic activity within the extracellular media was measured following 24 hours of 
culture in LB supplemented with glucose in concentrations ranging from 0-20 mM (Fig 
5.10). Firstly, there was clear amylolytic activity detected in the extracellular media 
indicating glucoamylase was secreted via regulation from PcstA. Secondly, the amylolytic 
activity detected decreased as glucose concentration increased, mirroring observations 
from the previous characterisation of PcstA using eGFP (Fig 5.8). 
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Figure 5.10 Characterisation of PcstA regulated C. violaceum glucoamylase secretion in LB 
media supplemented with 0-20 mM glucose 
Glucoamylase activity in the extracellular media of E. coli W3110 harbouring pQR1715 
cultured for 24 hours at 37°C, 250 rpm, determined by amylase assay (degradation of 
starch measured by the absorbance of starch-iodine complex at 600 nm) and expressed in 
units (defined as the disappearance of 1 mg/mL starch-iodine complex per minute) per 
gram of dry cell weight. Error bars represent standard deviation, n=3.   
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5.4.4 The influence of PcstA regulated C. violaceum glucoamylase expression on 
starch degradation within LB media  
 
 
Figure 5.11 PcstA regulated expression of C. violaceum glucoamylase by E. coli and its 
influence on growth and the degradation of starch within LB media  
E. coli strains cultured at 37°C, 250 rpm over 24 hours in either LB (black) or LB 
supplemented with 2.5 mg/mL starch (grey). a) Growth curves from single experimental run 
for untransformed W3110 (square), W3110 harbouring pQR1715 (triangle), untransformed 
BL21(DE3) (circle), or BL21(DE3) harbouring pQR1715 (diamond) in both media 
compositions. b) Residual starch concentrations for untransformed W3110 (square, 
dashed), W3110 harbouring pQR1715 (triangle), untransformed BL21(DE3) (circle, dashed), 
or BL21(DE3) harbouring pQR1715 (diamond).  
 
When cultured in LB media supplemented with 2.5 mg/mL starch the expression of the C. 
violaceum glucoamylase under the PcstA promoter offered no advantage in terms of cell 
density over the untransformed controls (Fig 5.11a). This is consistent with previous results 
seen in Chapter 3 in which the expression of the S. thermoviolaceus α-amylase also offered 
no advantage (Figs 3.7a and 3.10a), and supports the conclusion that the starch provided as 
a supplement in LB enhances growth regardless of amylolytic enzyme expression. However, 
in terms of starch degradation within the media, the PcstA regulated expression and 
secretion of glucoamylase had a significant influence on the W3110 strains ability to 
degrade starch (Fig 5.11b). Given that untransformed BL21(DE3) is capable of rapid starch 
degradation anyway (Fig 3.10b), the PcstA regulated expression of glucoamylase offered 
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little increase and further investigation would be needed to determine whether there was 
a real difference between the two. However, seeing as it has already been established that 
high glucose concentration in shake flasks has little effect on the growth of BL21(DE3), this 
is an avenue which has not been pursued any further.   
5.4.5 Growth characteristics of E. coli W3110 expressing PcstA regulated C. 
violaceum glucoamylase cultured in glucose free MSM with starch-agar 
layers 
E. coli W3110 expressing C. violaceum glucoamylase under the regulation of PcstA was able 
to grow with starch as a sole carbon source, and was capable of achieving densities 
approximately twice that of cultures grown in an equivalent amount of glucose (Fig 5.12a). 
This is the first demonstration of increased cell densities having been achieved as a direct 
result of self-regulated enzyme-based fed-batch fermentation. Based on the previous 
characterisation studies of PcstA, it was expected that secretion of C. violaceum 
glucoamylase would be lower in cultures containing glucose, and higher in cultures 
containing starch. Surprisingly, when amylolytic activity in the extracellular media was 
measured there was no obvious difference between media containing starch and media 
containing glucose (Fig 5.12b). When normalised to dry cell weight, amylolytic activity in 
the extracellular media for both starch and glucose reduced and then plateaued, but again 
there was no discernible difference between the two media types. Further investigation 
would be required to explain why expression in culture conditions did not completely 
reflect the previous characterisation studies, however, for the purposes of this study the 
increase in cell density seen in starch compared to glucose is of greater importance, and 
provides a proof of principle that biomass can be enhanced via the self-secretion of an 
amylolytic enzyme when cells are grown in media containing starch compared with an 
equivalent amount of glucose.  
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Figure 5.12 PcstA regulated C. violaceum glucoamylase expression and its influence on 
growth in MSM containing starch-agar layers 
E. coli W3110 harbouring pQR1715 (BBa_K118011-CV2DsbA) cultured for 72 hours at 30°C, 
180 rpm, in either glucose free MSM with starch-agar layers (grey) or MSM supplemented 
with 50 mg/mL glucose (black). a) Growth curves for each condition in duplicate. b) 
Glucoamylase activity in the extracellular media determined by amylase assay at 37°C and 
expressed as units per mL of culture. c) Glucoamylase activity in the extracellular media 
determined by amylase assay at 37°C and expressed as units per gram of dry cell weight.  
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5.5 Co-expression studies as a method for developing a 
heterologous protein expression system utilising starch as a 
carbon source 
5.5.1 Co-expression of S. thermoviolaceus α-amylase and an E. coli derived 
transketolase  
To investigate if a recombinant protein of interest could be co-expressed alongside S. 
thermoviolaceus α-amylase, a transketolase (TK) originally derived from E. coli was used. E. 
coli BL21(DE3) was co-transformed with pQR187 and the compatible plasmid pQR411 [80] 
(a pMMB67HE backbone vector containing an RSF1010 origin of replication and the E. coli 
derived TK), and grown up in LB for 24 hours at 37°C, 250 rpm (induced with 0.4 mM IPTG 
at inoculation (1 in 20 dilution of an overnight culture)). Although co-expression of the two 
enzymes was achieved, SDS page analysis revealed a qualitative reduction in TK expression 
(band at 75 kDa) from the co-expression strain compared with the strain expressing TK only 
(Fig 5.13a). In this particular example the expression of α-amylase was also clear in the co-
expressing strain (band at 47 kDa). Given that the expression of α-amylase was highly 
visible on SDS page, and extracellular activity is generally known to be very high (Chapter 3 
discussion), it may be possible that the marked reduction in expression of TK was due to 
the over expression of α-amylase.   
To investigate the potential of using the increased cell mass gained from high density 
cultures to increase expression of heterologous protein, experiments were conducted using 
the commercially available EnPresso® growth system. Co-transformed BL21(DE3) were 
cultured using the EnPresso® protocol described in the materials and methods (section 
2.4.4), alongside controls of BL21(DE3) expressing TK only and BL21(DE3) expressing TK 
only, but without the addition of reagent A. Despite matching the final cell density with an 
OD600 of approximately 33 (OD600 data shown in Figure legend), the co-expressing strain did 
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not express TK as highly as the single expressing TK strain under the EnPresso® conditions 
(Fig 5.13b). In fact, qualitatively, the co-expressing strain produced a similar amount of TK 
as the strain expressing TK only, without the addition of reagent A. This suggests expression 
levels of TK were decreased in the co-expression strain to such an extent that even the 
associated increase in cell density did not offset the reduction in expression.  
 
 
 
Figure 5.13 SDS-page analysis for the co-expression of S. thermoviolaceus α-amylase and 
an E. coli derived transketolase 
a) SDS-page of clarified lysate for untransformed E. coli W3110, W3110 harbouring 
pQR411, untransformed BL21(DE3), BL21(DE3) harbouring pQR411, and BL21(DE3) 
harbouring both pQR411 and pQR187, grown in LB for 24 hours at 37°C, 250 rpm. Sample 
volume processed was normalised to cell density b) SDS-page of clarified lysate for 
BL21(DE3) (OD600 of 18), BL21(DE3) harbouring pQR411 (with reagent A) (OD600 of 29), 
BL21(DE3) harbouring pQR411 (without reagent A) (OD600 of 21),  and BL21(DE3) 
harbouring both pQR411 and pQR187 (without reagent A) (OD600 of 33) grown in EnPresso® 
growth media as per the standard protocol (see section 2.4.4). Cultures contained the 
appropriate antibiotics when necessary to maintain plasmid stability (see materials and 
methods), and were induced with 0.4 mM IPTG at inoculation (1 in 20 dilution from an 
overnight culture) when necessary. Labelled arrows indicate position of TK (75 kDa) and α-
amylase (47 kDa).  
 
a b 
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5.5.2 Co-expression of C. violaceum glucoamylase and an E. coli derived 
transketolase  
Previous studies have indicated that co-expression does not necessarily lead to a reduction 
in expression [6], however, it is possible that the overexpression of S. thermoviolaceus α-
amylase  results in a metabolic burden rendering co-expression non-viable. To determine 
whether co-expression could be a viable option, TK from pQR411 was co-transformed into 
E. coli W3110 with the lesser expressed PcstA regulated C. violaceum glucoamylase. Co-
expression of TK from pQR411 and the PcstA regulated C. violaceum glucoamylase 
containing the DsbA signal sequence (pQR1715) was carried out in flasks containing glucose 
free MSM with starch-agar layers. The growth curves for the co-expressing strain mirrored 
those seen in cells expressing C. violaceum glucoamylase only, albeit with a slightly delayed 
onset of log phase (Fig 5.14a). This was likely due to the decrease in glucoamylase activity 
within the media (Fig 5.14b) compared to cells expressing C. violaceum glucoamylase only, 
indicating that glucoamylase expression was reduced when expressed alongside pQR411. 
When this co-expressing strain was grown in MSM containing an equivalent amount of 
glucose, the final densities achieved were similar to those seen previously by the strain 
expressing glucoamylase only. However, when final cell pellets were analysed by SDS page, 
TK expression was not obvious (Fig 5.14d). 
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Figure 5.14 Co-expression of PcstA regulated C. violaceum glucoamylase and an E. coli 
derived transketolase 
E. coli W3110 harbouring pQR1715 (BBa_K118011-CV2DsbA) and pQR411 cultured for 72 
hours at 30°C, 180 rpm, in either glucose free MSM with starch-agar layers (grey) or MSM 
supplemented with 50 mg/mL glucose (black). a) Growth curves for each condition in 
duplicate. b) Glucoamylase activity in the extracellular media determined by amylase assay 
at 37°C and expressed as units per mL of culture. c) Glucoamylase activity in the 
extracellular media determined by amylase assay at 37°C and expressed as units per gram 
of dry cell weight. d) SDS page of samples removed at 72 hours (1) whole cell lysate of 
W3110 harbouring pQR1715 cultured in glucose free MSM with starch-agar layer, (2) 
clarified cell lysate of W3110 harbouring pQR1715 cultured in glucose free MSM with 
starch-agar layer, (3) whole cell lysate of W3110 harbouring pQR1715 cultured in MSM 
supplemented with 50 mg/mL glucose, (4) Clarified cell lysate of W3110 harbouring 
pQR1715 cultured in MSM supplemented with 50 mg/mL glucose. Arrow indicates 
expected position of TK (at 75 kDa).  
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5.6 Dual-expression studies as a method for developing a 
heterologous protein expression system utilising starch as a 
carbon source 
Some of the complications surrounding co-expression could be potentially mitigated by 
constructing an operon on a single plasmid, termed here dual-expression. Compatibility 
issues and the metabolic burden associated with multiple antibiotic resistance genes would 
be eliminated, along with simplifying the transformation method. It would also provide a 
basis for a versatile system whereby a plasmid already containing a self-regulated 
amylolytic enzyme could be designed to contain a multiple cloning site for insertion of an 
additional gene of interest, similar in concept to current commercially available vectors 
such as pETDuet™ (Novagen) or pACYCDuet™ (Novagen), but specifically for high density 
growth using starch as the substrate.  
5.6.1 Construction of pQR1716 (pUC19-Amy) and pQR1717 (pUC19-GFP) 
Initially, control vectors containing either S. thermoviolaceus α-amylase or eGFP were 
constructed using circular polymerase extension cloning (CPEC) (Fig 5.15). The vector 
backbones were derived from pUC19 [81], which carries ampicillin resistance, and contains 
the lac promotor allowing for expression in both E. coli BL21(DE3) and W3110. CPEC 
construction involved the designing of overlapping primers at each intersection between 
insert and vector. In the case of pQR1716 and pQR1717, there is one insert in each vector, 
resulting in two primer pairs used for initial amplification reactions. pQR1716 construction 
used AmyCPEC1.fw and AmyCPEC1.rv primers for insert amplification, and pUC19CPEC1.fw 
and pUC19CPEC1.rv primers for vector amplification, with pQR187 and pUC19 acting as 
respective templates in standard PCR conditions (described in section 2.2.3). pQR1717 
construction used CPEC2_GFP.fw and CPEC2_GFP.rv primers for insert amplification, and 
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CPEC2_pUC19.fw and CPEC2_pUC19.rv primers for vector amplification, with pET29a-GFP 
and pUC19 acting as respective templates. PCR products were gel extracted, purified, and 
combined for respective CPEC reactions (see section 2.2.4 for details). Both resulting 
constructs were confirmed using restriction digestion analysis and sequencing.   
 
 
Figure 5.15 Construction of pQR1716 (pUC19-Amy) and pQR1717 (pUC19-GFP) using 
Circular Polymerase Extension Cloning 
Vector maps and primer design for construction of a) pQR1716 and b) pQR1717, using 
Circular Polymerase Extension Cloning (CPEC).  
         
a 
b 
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5.6.2 Construction of dual-expression vectors pQR1718 (pUC19-AmyGFP) and 
pQR1719 (pUC19-GFPAmy) 
The first construction of a dual-expression vector combined S. thermoviolaceus α-amylase 
and eGFP, using CPEC in the same way as above. Two inserts required three primer pairs 
(one at each intersection between the vector and insert 1, insert 1 and insert 2, and insert 2 
and the vector), as highlighted in Fig 5.16. Prior to the CPEC reaction three separate PCRs 
were required to amplify the two inserts and one vector. Insert 1 (S. thermoviolaceus α-
amylase) was amplified using AmyCPEC1.rv and CPEC7_Amy.fw primers, with pQR187 as 
the template. Insert 2 (eGFP) was amplified using CPEC7_GFP.rv and CPEC2_GFP.rv 
primers, with pET29a-eGFP as the template. The vector (pUC19 backbone) was amplified 
using CPEC2_pUC19.rv and pUC19CPEC1.fw primers, with pUC19 as the template. PCR 
reactions followed standard conditions described in section 2.2.3. Following gel extraction 
and purification the subsequent PCR products were used in a CPEC reaction with conditions 
optimised for multiple inserts (see section 2.2.4 for details). The resulting construct, 
pQR1718 was confirmed using restriction digestion analysis and sequencing. A vector was 
also constructed using the same method but with primers containing the inserts in the 
reverse order i.e. eGFP upstream of the S. thermoviolaceus α-amylase. This was in an 
attempt to optimise GFP expression, adhering to the notion that genes are more highly 
expressed on an operon the closer they are to the promoter [98]. The resulting construct 
was designated pQR1719.       
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Figure 5.16 Vectors designed for dual-expression of eGFP and α-amylase   
Vector maps of a) pQR1718 (pUC19AmyGFP) and b) pQR1719 (pUC19GFPAmy) along with 
primers used for initial PCR reactions. The final construction step used multi insert CPEC.  
a 
b 
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5.6.3 Expression and activity from dual-expression plasmids 
As expected cells harbouring pQR1719 showed increased GFP fluorescence over those 
harbouring pQR1718 (Fig 5.17a), though surprisingly the reverse was not true for amylase 
activity. In fact, amylase activity in the extracellular media was marginally increased in cells 
harbouring pQR1719 compared with those harbouring pQR1718 (Fig 5.17b). Overall, 
expression from the dual-expression plasmid mirrored previous co-expression results in 
that expression of a recombinant protein of interest was significantly reduced when 
expressed concurrently with an amylolytic enzyme.     
 
 
Figure 5.17 eGFP fluorescence and α-amylase activity from dual-expression vectors 
E. coli W3110 harbouring pQR1718 (pUC19AmyGFP), pQR1719 (pUC19GFPAmy) or 
pQR1717 (pUC19GFP), cultured in LB media at 37°C, 250 rpm for 24 hours (induced with 
0.4 mM IPTG at an OD600 of 0.6-0.8). a) eGFP fluorescence intensity measured from neat 
whole cell samples using an excitation wavelength of 483 nm and an emission wavelength 
of 535 nm (Tecan infinite 200 pro). Fluorescence units were normalised to OD600. b) 
Extracellular media α-amylase activity determined by amylase assay and expressed as units 
per mL of cell culture volume. Error bars represent standard deviation, n=3.   
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5.6.4 Dual-expression using starch as a sole carbon source 
 
Figure 5.18 Growth and eGFP expression of E. coli W3110 harbouring the pQR1719 dual-
expression vector cultured in glucose free MSM supplemented with 2.5 mg/mL starch 
E. coli W3110 harbouring either pQR1716 (pUC19-Amy) or pQR1719 (pUC19-GFPAmy), 
cultured in glucose free MSM supplemented with 2.5 mg/mL starch, or MSM only (control), 
at 37°C, 250 rpm for 24 hours (induced with 0.4 mM IPTG at inoculation (initial OD600 of 
0.25)).  a) Cell density determined by OD600 following a culture period of 24 hours. b) Total 
eGFP fluorescence intensity measured from neat whole cell samples using an excitation 
wavelength of 483 nm and emission wavelength of 535 nm (Tecan infinite 200 pro). Error 
bars represent standard deviation, n=3.  
 
E. coli W3110 harbouring pQR1719 was able to grow in glucose free MSM supplemented 
with 2.5 mg/mL starch i.e. the dual-expression strain was able to utilise starch as a sole 
carbon source (Fig 5.18a), and was capable of achieving cell densities similar to those seen 
with W3110 harbouring the amylase only vector, pQR1716. However, total eGFP 
expression, despite being greater than the pQR1716 control, did not increase throughout 
the 24 hour culture, as indicated by the inoculum control (Fig 5.18b). The inoculum control 
comprised glucose free MSM only, and was inoculated with the same volume of LB starter 
culture. The lack of carbon prevented cells from growing in density beyond the initial 
inoculum and gave an indication of eGFP expression already present within the inoculum. 
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Despite observing eGFP expression in LB media, these results indicate dual-expression from 
pQR1719 did not lead to significant production of eGFP in defined media with starch as a 
sole carbon source. 
5.6.5 Dual-expression of C. violaceum glucoamylase and eGFP 
 
Figure 5.19 Vector designed for dual-expression of eGFP and C. violaceum glucoamylase   
Vector map of pQR1720, constructed using multiple insert CPEC following insert and vector 
PCR reactions using primer pairs indicated.   
 
Given the apparent problems associated with the dual-expression of eGFP and α-amylase, a 
vector was constructed replacing α-amylase with C. violaceum glucoamylase containing the 
DsbA signal sequence, in an attempt to increase eGFP expression while utilising starch as a 
sole carbon source. The rationale followed previous observations whereby C. violaceum 
glucoamylase is generally less well expressed than S. thermoviolaceus α-amylase regardless 
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of the promotor and RBS combination used, yet still leads to an enhancement of cell mass 
when starch is used as the sole carbon source. With the assumption that a less well 
expressed enzyme will assert a lower metabolic burden on the cell, it may be possible that 
the expression of a second protein would be increased, even in defined media containing 
starch as the only carbon source. The pQR1720 vector (Fig 5.19) was constructed using 
CPEC in the same way as pQR1719; with insert 1 (eGFP) amplified using CPEC8_GFP.rv and 
CPEC9_GFP.fw primers, with pQR1344 as the template, insert 2 (C. violaceum glucoamylase 
with attached DsbA signal sequence) amplified using CPEC9_CVprimer2Dsb.rv and 
CPEC9_CVprimer2Dsb.fw primers, with pQR1712 as the template, and the vector backbone 
amplified using CPEC9_pUC19.rv and CPEC8_pUC19.fw primers, with pUC19 as the 
template. Construction was confirmed by sequencing. 
When cultured in flasks containing glucose free MSM and starch-agar layers, E. coli W3110 
harbouring pQR1720 achieved densities similar to those which have been seen previously 
with the pQR1715 construct, driving expression of the C. violaceum glucoamylase alone. 
Furthermore, total eGFP expression was greatly increased throughout the culture period, 
particularly when compared to cultures containing an equivalent amount of glucose. This is 
the first demonstrated example of enhanced recombinant protein expression resulting 
directly from a self-secreting enzyme-based fed-batch fermentation system.      
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Figure 5.20 Dual-expression of C. violaceum glucoamylase and eGFP in E. coli W3110 
harbouring pQR1720 
E. coli W3110 harbouring pQR1720, cultured in flasks containing glucose free MSM with 
starch-agar layers or MSM supplemented with 50 mg/mL glucose, at 37°C, 250 rpm for 48 
hours (induced with 0.4 mM IPTG at inoculation (initial OD600 of 0.25)). a) Increase in cell 
density (OD600) over 48 hours of culture for each media type. b) Increase in extracellular 
media glucoamylase activity over 48 hours for each media type, expressed in units of 
glucoamylase activity per mL of culture, determined by amylase assay (absorbance of 
starch-iodine complex at 600 nm). c) Increase in total eGFP fluorescence units over 48 
hours for each media type, measured from neat whole cell samples using an excitation 
wavelength of 483 nm and emission wavelength of 535 nm (Tecan infinite 200 pro). d) 
Image of eGFP expression under blue light for each media composition, displayed in 
triplicate. Error bars represent standard deviation, n=3.    
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5.7 Discussion and Conclusion  
A major objective of this Chapter was to examine the application of a cell engineering 
approach to enzyme-based fed-batch fermentation. As a proof of concept, E. coli secreting 
S. thermoviolaceus α-amylase cultured in EnPresso® growth media, lacking the additional 
amylolytic reagent, was shown to achieve cell densities in excess of the control that lacked 
α-amylase but included the exogenously added amylolytic reagent A. The enhanced cell 
growth observed confirms cell engineering is a viable option for enzyme-based fed-batch 
fermentation, however, given the rate at which extracellular starch is degraded by S. 
thermoviolaceus α-amylase, it also raises some questions as to whether the true 
mechanism is based on the slow release of utilisable carbon or simply that utilisable carbon 
is liberated from starch. Given that the predominant hydrolysis products of S. 
thermoviolaceus α-amylase are short oligosaccharides rather than glucose (see section 
3.3.5), the latter seems more likely. Furthermore, owing to the degree of impenetrability 
surrounding the identity of components within EnPresso® growth media, there were 
difficulties in determining the exact nature of carbon present in the cultures to begin with.  
To investigate the slow release of utilisable carbon and truly mimic fed-batch fermentation, 
a combination of defined media (glucose free MSM) and starch-agar layers were developed 
alongside E. coli W3110 strains able to express and secrete C. violaceum glucoamylase 
using a glucose sensitive promoter. The increase in cell density within flasks containing 
starch compared with those containing glucose is the first demonstration of a cell 
engineering approach to self-regulated enzyme-based fed-batch fermentation. The main 
caveat to this system is that, for shake flasks at least, it may be specific to K12 strains, as 
BL21(DE3) appear not to benefit from the slow release of glucose from starch, presumably 
because they do not demonstrate any detrimental effects in terms of growth from high 
concentrations of glucose in the first place. As discussed previously this is likely a result of 
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the B strains ability to employ a glyoxylate shunt, reducing the accumulation of acetate and 
minimising the detrimental effects of overflow metabolism [47-51].    
In an attempt to use this enhanced cell mass as a platform for recombinant protein 
expression, simultaneous expression of both an amylolytic enzyme and a recombinant 
protein of interest was investigated. Initial experiments using a two vector system 
indicated that co-expression had the effect of reducing the level of expression for each 
individual protein, compared with expression from the same constructs when present on 
their own. Despite the increased cell density, expression of the recombinant protein of 
interest (TK) remained at a lower level than the single expressing control. Single vectors 
containing operons were constructed as an alternative to multi-vector co-expression. While 
these dual-expression vectors provide certain technical advantages such as eliminating the 
need for co-transformation and reducing the requirement for multiple types of antibiotic, it 
was thought that they may also lead to higher levels of protein due to a reduced metabolic 
burden on the host cell. The construction of pQR1720 which includes an operon containing 
eGFP immediately followed by the C. violaceum glucoamylase, regulated by the lac 
promoter, demonstrated for the first time recombinant protein expression using starch as a 
sole carbon source. Furthermore, the yield of recombinant protein (eGFP) was greater in 
cultures containing starch than in cultures containing an equivalent amount of glucose. This 
is the first example of enhanced recombinant protein expression resulting directly from a 
cell engineered approach to enzyme-based fed-batch fermentation.     
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6 Conclusions and Future work 
This study has provided evidence to suggest that the construction of amylolytic E. coli 
strains could allow starch to be used as a viable alternative to other carbon sources during 
fermentation. More specifically, through the identification and characterisation of novel 
bacterial glucoamylases, and the combination of these with regulatory elements and 
secretory signal peptides, a cell engineering approach to enzyme-based fed-batch 
fermentation has been demonstrated for the first time via enhanced cell growth and an 
associated increase in recombinant protein yield.  
With a proof of concept firmly established, further development of this project can be 
divided into a number of areas. One avenue would be to integrate the C. violaceum 
glucoamylase into the host genome, ideally using a glucose sensitive promoter for 
regulation. This should theoretically eliminate some of the issues associated with 
maintaining multiple plasmids within one cell, and increase the systems versatility. 
Preliminary investigations into genome integration were carried out using a temperature 
sensitive vector pGRG36 designed for site-specific insertions of transgenes using the 
transposon Tn7 [99]. Growth at permissive temperatures of 32°C allows for the 
recombination machinery present on the plasmid to insert the transgene (present within 
the plasmids multiple cloning site) into the Tn7 attachment site (attTn7) in the genome. 
Increasing the temperature to 37°C cures the cells of the vector. The C. violaceum 
glucoamylase along with the PcstA promoter and the DsbA signal peptide were sub-cloned 
into the pGRG36 and transformed into chemically competent E. coli W3110 cells, however 
no amylolytic activity was detected from colonies tested. Further work is needed to 
determine the reasons for this, and to explore whether the substantial reduction in gene 
copy number compared with vector based expression would be adequate within this 
particular system. 
150 
 
Alternatively, the dual-expression vector-based system could be further optimised, and 
modified to include a multiple cloning site to facilitate the insertion of genes for 
recombinant expression. The dual-expression vectors used in this study contain an operon 
regulated by the lac promoter; further modifications could include separate promoters 
independently regulating the expression of the amylolytic enzyme and the recombinant 
protein of interest, essentially mimicking current commercially available dual-expression 
vectors such as pETDuet™ (Novagen) or pACYCDuet™ (Novagen), whereby two genes are 
regulated by independent promoters. However, unlike these commercially available 
vectors the amylolytic enzyme would ideally be self-regulated i.e. controlled by a PcstA-like 
promoter, while the recombinant protein cloned into the multiple cloning site could be 
regulated by a strong inducible promoter. Given that self-secreting enzyme-based fed-
batch fermentation has been realised only in E. coli W3110 and not in BL21(DE3), it is 
important to select a promoter compatible with K12 strains, such as Ptac.    
This method of self-secreting enzyme-based fed-batch fermentation is not limited to the 
degradation of starch. The same principle could be applied to alternative carbon sources 
such as cellulose. By engineering an E. coli strain with the ability to secrete cellulase into 
the extracellular media, it may be possible to release glucose in a similar manner. Initial 
investigations using the cAZY database [54] identified a number of cellulases of potential 
interest from D. geothermalis. It is possible that a combination of cellulases would be 
required, including endo-acting cellulases (EC 3.2.1.4) for the initial hydrolysis of cellulose, 
exo-acting cellulases (EC 3.2.1.91) to form cellobiose, and cellobiases (EC 3.2.1.21) for final 
hydrolysis of cellobiose into glucose. An obvious advantage, much like starch, is the 
ubiquity of cellulose as a carbon source. However, the insolubility of cellulose in water 
could provide a major obstacle in applying it to a liquid based culture.  
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Another potential improvement over the current system lies with altering the mechanism 
behind secretion. It may be possible to avoid relying on outer membrane permeability for 
secretion by anchoring amylolytic enzymes to the cells outer surface. This may allow for a 
smaller amount of enzyme to be produced whilst still maintaining the desired feed rate, 
based on the rationale that when the enzyme is targeted to the periplasm for periplasmic 
release, a proportion of that enzyme never comes into contact with its substrate in the 
extracellular media. Whereas, if the amylolytic enzyme is targeted directly to the outer 
surface, all enzyme produced will have access to the substrate. If less amylolytic enzyme is 
required this has the potential to reduce the overall metabolic burden on the cell and may 
allow for increased cell growth and increased recombinant protein yield. Furthermore, the 
mechanism behind periplasmic leakage itself is not completely understood, with reports 
suggesting a possible correlation between periplasmic protein concentration and release 
[100], and others suggesting additional factors such as outer membrane composition 
playing a more significant role [101]. Either way, avoiding this step would provide a more 
direct link between transcription and functional expression, allowing for more precise 
regulatory control. In addition, having the amylolytic enzyme attached to the cell 
membrane could simplify any issues in downstream processing, which may arise from the 
amylolytic enzyme and the recombinant protein of interest being present in the same 
subcellular fraction. The idea of cell surface display for polysaccharide degradation has 
been explored previously, with one example being a cello-oligosaccharide assimilating E. 
coli strain displaying an active β-glucosidase anchored to the cell surface via the Blc protein 
[102]. The Blc protein itself is an outer membrane lipoprotein endogenous to E. coli, and 
was in this case fused via its C-terminus to the N-terminus of the β-glucosidase. Another 
example has been the use of auto-transporters, a family of proteins which use the type V 
secretion pathway to deliver proteins to the cell surface in Gram-negative bacteria [103]. 
The advantage of this system is that it is modular, consisting of an N-terminal signalling 
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sequence, a passenger domain containing the protein to be displayed, and a membrane 
anchored C-terminal translocation unit [104]. More recently an auto-transporter was used 
to display a thermophilic β-glucosidase from Thermobifida fusca onto the cell surface of the 
E. coli strain MS04, for the purposes of carrying out simultaneous saccharification and 
fermentation in the production of lignocellulosic biofuels [105].  
Investigations within this study have also shed light on previously unreported observations 
that E. coli, particularly BL21(DE3), is able to degrade starch without the heterologous 
expression of an amylolytic enzyme , however the reasons behind this remain unclear. 
Further work is needed to gain a more complete picture about the endogenous enzyme 
responsible, and why there is such a disparity between BL21(DE3) and W3110. It is already 
known that expression levels of certain proteins including those of the maltose transporter 
are increased in BL21 compared to K12 strains [106]. It is certainly possible that amylolytic 
enzymes involved in this pathway are also upregulated in BL21(DE3), explaining the 
increased ability to degrade starch within the media. An interesting observation is that the 
amylolytic enzyme in question is not secreted, but is instead associated with the cell itself, 
indicating that starch molecules are capable of being degraded by enzymes residing in 
either the periplasmic space or at the outer membrane. A key piece of work still remaining 
is to identify the hydrolysis products from this endogenous enzyme, and establish why E. 
coli BL21(DE3) appears not to be able to utilise those products for growth. 
In summary this study has investigated the utilisation of starch as a carbon source in both 
untransformed and engineered amylolytic E. coli strains. The characterisation of S. 
thermoviolaceus α-amylase secreting E. coli reveals it to be a particularly potent amylolytic 
strain, with potential applications as a microbial platform to convert starch into valuable 
products. The development of additional novel amylolytic strains has allowed for the direct 
conversion of starch to glucose within the culture media. The outcome is an innovative 
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solution to one of the fundamental issues associated with microbial fermentation, and 
provides the first reported example of self-secreting enzyme-based fed-batch 
fermentation, resulting in both increased cell density and increased recombinant protein 
yield.  
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